☰

Eugene Braunwald - Publications

Affiliations: 
1968 National Institutes of Health, Bethesda, MD 
 1968-1972 University of California, San Diego School of Medicine, San Diego, CA, United States 
 1972- Harvard Medical School, Boston, MA, United States 
Website:
http://www.nasonline.org/member-directory/members/57428.html
Tree Info Similar researchers PubMed Report error

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Mann DL, Nicolas J, Claggett B, Miao ZM, Granger CB, Kerkar P, Køber L, Lewis EF, McMurray JJV, Maggioni AP, Núñez J, Ntsekhe M, Rouleau JL, Sim D, Solomon SD, ... ... Braunwald E, et al. Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI. Journal of the American College of Cardiology. 83: 904-914. PMID 38418004 DOI: 10.1016/j.jacc.2024.01.002  0.313
2023 Jering KS, Claggett BL, Pfeffer MA, Granger CB, Køber L, Lewis EF, Maggioni AP, Mann DL, McMurray JJV, Prescott MF, Rouleau JL, Solomon SD, Steg PG, von Lewinski D, Braunwald E. Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial. Circulation. Heart Failure. e010259. PMID 37125529 DOI: 10.1161/CIRCHEARTFAILURE.122.010259  0.306
2021 Sabatine MS, Braunwald E. Thrombolysis In Myocardial Infarction (TIMI) Study Group: JACC Focus Seminar 2/8. Journal of the American College of Cardiology. 77: 2822-2845. PMID 34082913 DOI: 10.1016/j.jacc.2021.01.060  0.318
2021 Jering KS, Claggett B, Pfeffer MA, Granger C, Køber L, Lewis EF, Maggioni AP, Mann D, McMurray JJV, Rouleau JL, Solomon SD, Steg PG, van der Meer P, Wernsing M, Carter K, ... ... Braunwald E, et al. Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristics. European Journal of Heart Failure. PMID 33847047 DOI: 10.1002/ejhf.2191  0.301
2020 Berardi C, Braunwald E, Morrow DA, Mulder HS, Duffy CI, O'Brien TX, Ambrosy AP, Chakraborty H, Velazquez EJ, DeVore AD. Angiotensin-Neprilysin Inhibition in Black Americans: Data From the PIONEER-HF Trial. Jacc. Heart Failure. PMID 32919915 DOI: 10.1016/J.Jchf.2020.06.019  0.302
2020 Antman EM, Braunwald E. Invasive or Conservative Strategy for Stable Coronary Disease. Reply. The New England Journal of Medicine. 383: e66. PMID 32877597 DOI: 10.1056/Nejmc2024008  0.3
2020 Ambrosy AP, Braunwald E, Morrow DA, DeVore AD, McCague K, Meng X, Duffy CI, Rocha R, Velazquez EJ. Angiotensin Receptor-Neprilysin Inhibition Based on History of Heart Failure and Use of Renin-Angiotensin System Antagonists. Journal of the American College of Cardiology. 76: 1034-1048. PMID 32854838 DOI: 10.1016/J.Jacc.2020.06.073  0.373
2020 Berg DD, Braunwald E, DeVore AD, Lala A, Pinney SP, Duffy CI, Gurmu Y, Velazquez EJ, Morrow DA. Efficacy and Safety of Sacubitril/Valsartan by Dose Level Achieved in the PIONEER-HF Trial. Jacc. Heart Failure. PMID 32800511 DOI: 10.1016/J.Jchf.2020.06.008  0.312
2020 Gaziano TA, Fonarow GC, Velazquez EJ, Morrow DA, Braunwald E, Solomon SD. Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection Fraction. Jama Cardiology. PMID 32785628 DOI: 10.1001/Jamacardio.2020.2822  0.321
2020 Marston NA, Bonaca MP, Jarolim P, Goodrich EL, Bhatt DL, Steg PG, Cohen M, Storey RF, Johanson P, Wiviott SD, Braunwald E, Sabatine MS, Morrow DA. Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines. Jama Cardiology. PMID 32756916 DOI: 10.1001/Jamacardio.2020.2981  0.3
2020 Mann DL, Greene SJ, Givertz MM, Vader JM, Starling RC, Ambrosy AP, Shah P, McNulty SE, Mahr C, Gupta D, Redfield MM, Lala A, Lewis GD, Mohammed SF, Gilotra NA, ... ... Braunwald E, et al. Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial. Jacc. Heart Failure. PMID 32641226 DOI: 10.1016/J.Jchf.2020.05.005  0.36
2020 Anker SD, Butler J, Khan MS, Abraham WT, Bauersachs J, Bocchi E, Bozkurt B, Braunwald E, Chopra VK, Cleland JG, Ezekowitz J, Filippatos G, Friede T, Hernandez AF, Lam CSP, et al. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Heart Journal. PMID 32498081 DOI: 10.1093/Eurheartj/Ehaa461  0.335
2020 Napp LC, Cammann VL, Jaguszewski M, Szawan KA, Wischnewsky M, Gili S, Knorr M, Heiner S, Citro R, Bossone E, D'Ascenzo F, Neuhaus M, Franke J, Sorici-Barb I, Noutsias M, ... ... Braunwald E, et al. Coexistence and outcome of coronary artery disease in Takotsubo syndrome. European Heart Journal. PMID 32484517 DOI: 10.1093/Eurheartj/Ehaa210  0.369
2020 Antman EM, Braunwald E. Managing Stable Ischemic Heart Disease. The New England Journal of Medicine. 382: 1468-1470. PMID 32227752 DOI: 10.1056/Nejme2000239  0.355
2020 Scirica BM, Bergmark BA, Morrow DA, Antman EM, Bonaca MP, Murphy SA, Sabatine MS, Braunwald E, Wiviott SD. Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome. Journal of the American College of Cardiology. 75: 1095-1106. PMID 32164882 DOI: 10.1016/J.Jacc.2019.12.067  0.371
2020 Zelniker TA, Braunwald E. Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 75: 422-434. PMID 32000955 DOI: 10.1016/J.Jacc.2019.11.031  0.306
2020 Bisbal F, Baranchuk A, Braunwald E, Bayés de Luna A, Bayés-Genís A. Atrial Failure as a Clinical Entity: JACC Review Topic of the Week. Journal of the American College of Cardiology. 75: 222-232. PMID 31948652 DOI: 10.1016/J.Jacc.2019.11.013  0.366
2019 Alkhalfan F, Nafee T, Yee MK, Chi G, Kalayci A, Plotnikov A, Braunwald E, Gibson CM. Relation of White Blood Cell Count to Bleeding and Ischemic Events in Patients With Acute Coronary Syndrome (from the ATLAS ACS 2-TIMI 51 Trial). The American Journal of Cardiology. PMID 31898965 DOI: 10.1016/J.Amjcard.2019.12.007  0.357
2019 Sarma AA, Braunwald E, Cannon CP, Guo J, Im K, Antman EM, Gibson CM, Newby LK, Giugliano RP, Morrow DA, Wiviott SD, Sabatine MS, O'Donoghue ML. Outcomes of Women Compared With Men After Non-ST-Segment Elevation Acute Coronary Syndromes. Journal of the American College of Cardiology. 74: 3013-3022. PMID 31865968 DOI: 10.1016/J.Jacc.2019.09.065  0.325
2019 DeVore AD, Braunwald E, Morrow DA, Duffy CI, Ambrosy AP, Chakraborty H, McCague K, Rocha R, Velazquez EJ. Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial. Jama Cardiology. PMID 31825471 DOI: 10.1001/Jamacardio.2019.4665  0.358
2019 Furtado RHM, Nicolau JC, Magnani G, Im K, Bhatt DL, Storey RF, Steg PG, Spinar J, Budaj A, Kontny F, Corbalan R, Kiss RG, Abola MT, Johanson P, Jensen EC, ... Braunwald E, et al. Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54. European Heart Journal. PMID 31811715 DOI: 10.1093/Eurheartj/Ehz821  0.412
2019 Inciardi RM, Giugliano RP, Claggett B, Gupta DK, Chandra A, Ruff CT, Antman EM, Mercuri MF, Grosso MA, Braunwald E, Solomon SD. Left atrial structure and function and the risk of death or heart failure in atrial fibrillation. European Journal of Heart Failure. PMID 31777160 DOI: 10.1002/Ejhf.1606  0.36
2019 Bhatt DL, Verma S, Braunwald E. The DAPA-HF Trial: A Momentous Victory in the War against Heart Failure. Cell Metabolism. 30: 847-849. PMID 31693879 DOI: 10.1016/J.Cmet.2019.10.008  0.348
2019 Bergmark BA, Kamphuisen PW, Wiviott SD, Ruff CT, Antman EM, Nordio F, Kuder JF, Mercuri MF, Lanz HJ, Braunwald E, Giugliano RP. Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 Trial. Circulation. PMID 31597460 DOI: 10.1161/Circulationaha.119.041346  0.301
2019 Berg DD, Wiviott SD, Scirica BM, Gurmu Y, Mosenzon O, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Johanson P, Johansson PA, Langkilde AM, Raz I, Braunwald E, et al. Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus. Circulation. PMID 31474116 DOI: 10.1161/Circulationaha.119.042685  0.316
2019 Qamar A, Giugliano RP, Bohula EA, Park JG, Jarolim P, Murphy SA, Blazing MA, Califf RM, Cannon CP, Braunwald E, Morrow DA. Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial. Journal of the American College of Cardiology. 74: 1057-1068. PMID 31439215 DOI: 10.1016/J.Jacc.2019.06.038  0.365
2019 Braunwald E. Diabetes, heart failure, and renal dysfunction: The vicious circles. Progress in Cardiovascular Diseases. 62: 298-302. PMID 31377223 DOI: 10.1016/J.Pcad.2019.07.003  0.337
2019 Bergmark BA, Bhatt DL, McGuire DK, Cahn A, Mosenzon O, Steg PG, Im K, Kanevsky E, Gurmu Y, Raz I, Braunwald E, Scirica BM. Metformin Use and Clinical Outcomes among Patients with Diabetes with or without Heart Failure or Kidney Dysfunction: Observations from the SAVOR-TIMI 53 Trial. Circulation. PMID 31362530 DOI: 10.1161/Circulationaha.119.040144  0.304
2019 Park S, Bergmark BA, Shi M, Lanz HJ, Chung N, Ruff CT, Antman EM, Braunwald E, Giugliano RP. Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial. Hypertension (Dallas, Tex. : 1979). HYPERTENSIONAHA11913. PMID 31352829 DOI: 10.1161/Hypertensionaha.119.13138  0.33
2019 Bach RG, Cannon CP, Giugliano RP, White JA, Lokhnygina Y, Bohula EA, Califf RM, Braunwald E, Blazing MA. Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial. Jama Cardiology. PMID 31314050 DOI: 10.1001/Jamacardio.2019.2306  0.335
2019 Dellborg M, Bonaca MP, Storey RF, Steg PG, Im KA, Cohen M, Bhatt DL, Ophuis TO, Budaj A, Hamm C, Spinar J, Kiss RG, Lopez-Sendon J, Kamensky G, Van de Werf F, ... ... Braunwald E, et al. Efficacy and Safety with Ticagrelor in Patients with Prior Myocardial Infarction in the Approved European label: Insights from PEGASUS-TIMI 54. European Heart Journal. Cardiovascular Pharmacotherapy. PMID 31218354 DOI: 10.1093/ehjcvp/pvz020  0.325
2019 Morrow DA, Velazquez EJ, DeVore AD, Prescott MF, Duffy CI, Gurmu Y, McCague K, Rocha R, Braunwald E. Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial. European Heart Journal. PMID 31093657 DOI: 10.1093/Eurheartj/Ehz240  0.429
2019 Zelniker TA, Jarolim P, Scirica BM, Braunwald E, Park JG, Das S, Sabatine MS, Morrow DA. Biomarker of Collagen Turnover (C-Terminal Telopeptide) and Prognosis in Patients With Non- ST -Elevation Acute Coronary Syndromes. Journal of the American Heart Association. 8: e011444. PMID 31020897 DOI: 10.1161/Jaha.118.011444  0.327
2019 Morrow DA, Velazquez EJ, DeVore AD, Desai AS, Duffy CI, Ambrosy AP, Gurmu Y, McCague K, Rocha R, Braunwald E. Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial. Circulation. PMID 30955360 DOI: 10.1161/Circulationaha.118.039331  0.367
2019 Armitage J, Baigent C, Barnes E, Betteridge DJ, Blackwell L, Blazing M, Bowman L, Braunwald E, Byington R, Cannon C, Clearfield M, Colhoun H, Collins R, Dahlöf B, Davies K, et al. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials The Lancet. 393: 407-415. PMID 30712900 DOI: 10.1016/S0140-6736(18)31942-1  0.314
2019 Zelniker TA, Ruff CT, Wiviott SD, Blanc JJ, Cappato R, Nordio F, Mercuri MF, Lanz H, Antman EM, Braunwald E, Giugliano RP. Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF-TIMI 48. European Heart Journal. Acute Cardiovascular Care. 8: 176-185. PMID 30039978 DOI: 10.1177/2048872618790561  0.355
2019 Cannon CP, Antman EM, Walls R, Braunwald E. Time as an Adjunctive Agent to Thrombolytic Therapy. Journal of Thrombosis and Thrombolysis. 1: 27-34. PMID 10603508 DOI: 10.1007/Bf01061992  0.359
2019 Cannon CP, Braunwald E. Time to Reperfusion: The Critical Modulator in Thrombolysis and Primary Angioplasty. Journal of Thrombosis and Thrombolysis. 3: 117-125. PMID 10602552 DOI: 10.1007/Bf00132404  0.389
2019 Gibson WJ, Gibson CM, Yee MK, Korjian S, Daaboul Y, Plotnikov AN, Burton P, Braunwald E. Safety and Efficacy of Rivaroxaban When Added to Aspirin Monotherapy Among Stabilized Post‐Acute Coronary Syndrome Patients: A Pooled Analysis Study of ATLAS ACS‐TIMI 46 and ATLAS ACS 2‐TIMI 51 Journal of the American Heart Association. 8. DOI: 10.1161/Jaha.118.009451  0.339
2019 Inciardi RM, Giugliano R, Claggett B, Ruff C, Gupta D, Antman E, Mercuri M, Grosso M, Rutman H, Braunwald E, Solomon S. Prognostic Role Of Left Atrial Dysfunction And Estimation Of Left Ventricular Filling Pressure On Heart Failure And Cardiovascular Death In Non Valvular Atrial Fibrillation: The Engage-Af Timi Echocardiographic Sub-Study Journal of the American College of Cardiology. 73: 1434. DOI: 10.1016/S0735-1097(19)32040-6  0.377
2019 Ambrosy AP, DeVore A, Morrow D, Braunwald E, Duffy C, McCague K, Rocha R, Velazquez E. Prior Exposure To A Conventional Renin-Angiotensin System Antagonist And Angiotensin Receptor-Neprilysin Inhibition In Acute Decompensated Heart Failure: A Prespecified Subgroup Analysis Of The Pioneer-Hf Trial Journal of the American College of Cardiology. 73: 1020. DOI: 10.1016/S0735-1097(19)31627-4  0.328
2019 DeVore A, Morrow D, Braunwald E, Duffy CI, Ambrosy AP, McCague K, Rocha R, Velazquez E. Effect Of Sacubitril/Valsartan Initiation On 30-Day Readmissions After A Hospitalization For Acute Decompensated Heart Failure: A Secondary Analysis Of The Pioneer-Hf Trial Journal of the American College of Cardiology. 73: 901. DOI: 10.1016/S0735-1097(19)31508-6  0.315
2019 Morrow DA, Velazquez E, DeVore A, Duffy CI, Prescott M, McCague K, Rocha R, Braunwald E. Effect Of Sacubitril/Valsartan On Biomarkers Of Myocardial Stress In Patients Hospitalized With Acute Heart Failure In Pioneer-Hf Journal of the American College of Cardiology. 73: 682. DOI: 10.1016/S0735-1097(19)31290-2  0.394
2019 Bergmark B, Morrow D, Bhatt DL, Raz I, Steg P, Mosenzon O, Gurmu Y, Braunwald E, Scirica BM. Natriuretic Peptides Versus A Clinical History Of Heart Failure For Risk Prediction In Patients With Diabetes Journal of the American College of Cardiology. 73: 681. DOI: 10.1016/S0735-1097(19)31289-6  0.313
2018 Bonaca MP, Wiviott SD, Morrow DA, Steg PG, Hamm C, Bhatt DL, Storey RF, Cohen M, Kuder J, Im K, Magnani G, Budaj A, Nicolau JC, Parkhomenko A, López-Sendón J, ... ... Braunwald E, et al. Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54. Journal of the American Heart Association. 7: e009260. PMID 30571502 DOI: 10.1161/Jaha.118.009260  0.442
2018 Fudim M, Ambrosy AP, Sun JL, Anstrom KJ, Bart BA, Butler J, AbouEzzeddine O, Greene SJ, Mentz RJ, Redfield MM, Reddy YNV, Vaduganathan M, Braunwald E, Hernandez AF, Borlaug BA, et al. High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network. Journal of the American Heart Association. 7: e010364. PMID 30561266 DOI: 10.1161/Jaha.118.010364  0.382
2018 Velazquez EJ, Morrow DA, DeVore AD, Duffy CI, Ambrosy AP, McCague K, Rocha R, Braunwald E. Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure. The New England Journal of Medicine. PMID 30415601 DOI: 10.1056/Nejmoa1812851  0.364
2018 Borlaug BA, Anstrom KJ, Lewis GD, Shah SJ, Levine JA, Koepp GA, Givertz MM, Felker GM, LeWinter MM, Mann DL, Margulies KB, Smith AL, Tang WHW, Whellan DJ, Chen HH, ... ... Braunwald E, et al. Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial. Jama. 320: 1764-1773. PMID 30398602 DOI: 10.1001/Jama.2018.14852  0.355
2018 Bonaca MP, Gutierrez JA, Cannon C, Giugliano R, Blazing M, Park JG, White J, Tershakovec A, Braunwald E. Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial. The Lancet. Diabetes & Endocrinology. PMID 30396865 DOI: 10.1016/S2213-8587(18)30290-0  0.301
2018 Correa S, Morrow DA, Braunwald E, Davies RY, Goodrich EL, Murphy SA, Cannon CP, O'Donoghue ML. Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome. Journal of the American Heart Association. 7: e009077. PMID 30371283 DOI: 10.1161/Jaha.118.009077  0.371
2018 Fanola CL, Ruff CT, Murphy SA, Jin J, Duggal A, Babilonia NA, Sritara P, Mercuri MF, Kamphuisen PW, Antman EM, Braunwald E, Giugliano RP. Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF - TIMI 48 Trial. Journal of the American Heart Association. 7: e008987. PMID 30369307 DOI: 10.1161/Jaha.118.008987  0.312
2018 Gutierrez JA, Scirica BM, Bonaca MP, Steg PG, Mosenzon O, Hirshberg B, Im K, Raz I, Braunwald E, Bhatt DL. Prevalence and Outcomes of Polyvascular (Coronary, Peripheral, or Cerebrovascular) Disease in Patients With Diabetes Mellitus (From the SAVOR-TIMI 53 Trial). The American Journal of Cardiology. PMID 30366601 DOI: 10.1016/J.Amjcard.2018.09.014  0.354
2018 Korjian S, Braunwald E, Daaboul Y, Mi M, Bhatt DL, Verheugt FWA, Cohen M, Bode C, Burton P, Plotnikov AN, Gibson CM. Usefulness of Rivaroxaban for Secondary Prevention of Acute Coronary Syndrome in Patients With History of Congestive Heart Failure (from the ATLAS-ACS-2 TIMI-51 Trial). The American Journal of Cardiology. PMID 30340765 DOI: 10.1016/J.Amjcard.2018.08.034  0.409
2018 Berg DD, Wiviott SD, Braunwald E, Guo J, Im K, Kashani A, Gibson CM, Cannon CP, Morrow DA, Bhatt DL, Mega JL, O'Donoghue ML, Antman EM, Newby LK, Sabatine MS, et al. Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials. European Heart Journal. PMID 30239711 DOI: 10.1093/Eurheartj/Ehy556  0.338
2018 Corbalán R, Nicolau JC, López-Sendon J, Garcia-Castillo A, Botero R, Sotomora G, Horna M, Ruff CT, Hamershock RA, Grip LT, Antman EM, Braunwald E, Giugliano RP. Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial. Journal of the American College of Cardiology. 72: 1466-1475. PMID 30236308 DOI: 10.1016/J.Jacc.2018.07.037  0.351
2018 AlKhalfan F, Kerneis M, Nafee T, Yee MK, Chi G, Plotnikov A, Braunwald E, Gibson CM. D-Dimer Levels and Effect of Rivaroxaban on Those Levels and Outcomes in Patients With Acute Coronary Syndrome (An ATLAS ACS-TIMI 46 Trial Substudy). The American Journal of Cardiology. PMID 30217378 DOI: 10.1016/J.Amjcard.2018.07.032  0.321
2018 Ambrosy AP, Cerbin LP, Fudim M, Clare RM, Lokhnygina Y, Braunwald E, Califf RM, Cannon CP, Tershakovec AM, Roe MT, Blazing MA. Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure Status. The American Journal of Cardiology. PMID 30180960 DOI: 10.1016/J.Amjcard.2018.07.034  0.363
2018 Zelniker TA, Braunwald E. Cardiac and Renal Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetes: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 72: 1845-1855. PMID 30075873 DOI: 10.1016/J.Jacc.2018.06.040  0.371
2018 Braunwald E. Cell-Based Therapy in Cardiac Regeneration: An Overview. Circulation Research. 123: 132-137. PMID 29976683 DOI: 10.1161/Circresaha.118.313484  0.369
2018 Gibson CM, Levitan B, Gibson WJ, Yee MK, Murphy SA, Yuan Z, Chakrabarti AK, Lee M, Braunwald E. Fatal or Irreversible Bleeding and Ischemic Events With Rivaroxaban in Acute Coronary Syndrome. Journal of the American College of Cardiology. 72: 129-136. PMID 29976285 DOI: 10.1016/J.Jacc.2018.04.055  0.339
2018 Aisenberg J, Chatterjee-Murphy P, Friedman Flack K, Weitz JI, Ruff CT, Nordio F, Mercuri MF, Choi Y, Antman EM, Braunwald E, Giugliano RP. Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction). Circulation. Cardiovascular Quality and Outcomes. 11: e003998. PMID 29748353 DOI: 10.1161/Circoutcomes.117.003998  0.371
2018 Tricoci P, Newby LK, Clare RM, Leonardi S, Gibson CM, Giugliano RP, Armstrong PW, Van de Werf F, Montalescot G, Moliterno DJ, Held C, Aylward PE, Wallentin L, Harrington RA, Braunwald E, et al. Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention. Jacc. Cardiovascular Interventions. 11: 856-864. PMID 29747915 DOI: 10.1016/J.Jcin.2018.02.006  0.389
2018 Bergmark BA, Udell JA, Morrow DA, Cannon CP, Steen DL, Jarolim P, Budaj A, Hamm C, Guo J, Im K, Kuder JF, Braunwald E, Sabatine MS, O'Donoghue ML. Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial. Jama Cardiology. PMID 29710336 DOI: 10.1001/Jamacardio.2018.0653  0.352
2018 Velazquez EJ, Morrow DA, DeVore AD, Ambrosy AP, Duffy CI, McCague K, Hernandez AF, Rocha RA, Braunwald E. Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial. American Heart Journal. 198: 145-151. PMID 29653636 DOI: 10.1016/J.Ahj.2018.01.004  0.364
2018 Braunwald E. Aortic Stenosis: Then and Now. Circulation. PMID 29650546 DOI: 10.1161/Circulationaha.118.033408  0.341
2018 Cavallari I, Cannon CP, Braunwald E, Goodrich EL, Im K, Lukas MA, O'Donoghue ML. Metabolic syndrome and the risk of adverse cardiovascular events after an acute coronary syndrome. European Journal of Preventive Cardiology. 2047487318763897. PMID 29537291 DOI: 10.1177/2047487318763897  0.344
2018 Daaboul Y, Korjian S, Plotnikov AN, Burton P, Braunwald E, Wiviott SD, Gibson CM. Rivaroxaban and Post-Stroke Neurological Outcomes in Patients With Acute Coronary Syndrome. Journal of the American College of Cardiology. 71: 1048-1049. PMID 29495985 DOI: 10.1016/J.Jacc.2017.12.045  0.313
2018 Butler J, Kalogeropoulos AP, Anstrom KJ, Hsue PY, Kim RJ, Scherzer R, Shah SJ, Shah SH, Velazquez EJ, Hernandez AF, Desvigne-Nickens P, Braunwald E. Diastolic Dysfunction in Individuals with Human Immunodeficiency Virus Infection: Literature Review, Rationale and Design of the Characterizing Heart Function on Anti-Retroviral Therapy (CHART) Study. Journal of Cardiac Failure. PMID 29482027 DOI: 10.1016/J.Cardfail.2018.02.001  0.323
2018 Braunwald E. André Cournand, Bellevue's Cardiopulmonary Laboratory, and Research on Heart Failure. Annals of the American Thoracic Society. 15: S12-S14. PMID 29461893 DOI: 10.1513/Annalsats.201706-433Kv  0.393
2018 Bansilal S, Bonaca MP, Cornel JH, Storey RF, Bhatt DL, Steg PG, Im K, Murphy SA, Angiolillo DJ, Kiss RG, Parkhomenko AN, Lopez-Sendon J, Isaza D, Goudev A, Kontny F, ... ... Braunwald E, et al. Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease. Journal of the American College of Cardiology. 71: 489-496. PMID 29406853 DOI: 10.1016/J.Jacc.2017.11.050  0.391
2018 Cavallari I, Ruff CT, Nordio F, Deenadayalu N, Shi M, Lanz H, Rutman H, Mercuri MF, Antman EM, Braunwald E, Giugliano RP. Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial. International Journal of Cardiology. PMID 29395361 DOI: 10.1016/J.Ijcard.2018.01.065  0.314
2018 Magnuson EA, Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Braunwald E, Sabatine MS, Cohen DJ. Reply: Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Analysis by Subgroups. Journal of the American College of Cardiology. 71: 108. PMID 29301623 DOI: 10.1016/J.Jacc.2017.10.079  0.4
2018 Eisen A, Giugliano RP, Braunwald E. Updates on Acute Coronary Syndrome: A Review. Jama Cardiology. 1: 718-30. PMID 27438381 DOI: 10.1001/Jamacardio.2016.2049  0.35
2018 Zelniker T, Jarolim P, Scirica B, Braunwald E, Park J, Das S, Sabatine M, Morrow DA. PROGNOSTIC VALUE OF BIOMARKER OF COLLAGEN TURNOVER (C-TERMINAL TELOPEPTIDE) IN PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROMES: INSIGHTS FROM MERLIN-TIMI 36 Journal of the American College of Cardiology. 71: A833. DOI: 10.1016/S0735-1097(18)31374-3  0.396
2017 Giugliano RP, Cannon CP, Blazing MA, Nicolau JC, Corbalan R, Spinar J, Park JG, White JA, Bohula E, Braunwald E. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With vs. Without Diabetes: Results from IMPROVE-IT. Circulation. PMID 29263150 DOI: 10.1161/Circulationaha.117.030950  0.343
2017 Korjian S, Braunwald E, Daaboul Y, Verheugt F, Bode C, Tendera M, Jain P, Plotnikov A, Burton P, Gibson CM. Safety and efficacy of rivaroxaban for the secondary prevention following acute coronary syndromes among biomarker-positive patients: Insights from the ATLAS ACS 2-TIMI 51 trial. European Heart Journal. Acute Cardiovascular Care. 2048872617745003. PMID 29249166 DOI: 10.1177/2048872617745003  0.369
2017 Scirica BM, Mosenzon O, Bhatt DL, Udell JA, Steg PG, McGuire DK, Im K, Kanevsky E, Stahre C, Sjöstrand M, Raz I, Braunwald E. Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial. Jama Cardiology. PMID 29214305 DOI: 10.1001/Jamacardio.2017.4228  0.31
2017 Kato ET, Cannon CP, Blazing MA, Bohula E, Guneri S, White JA, Murphy SA, Park JG, Braunwald E, Giugliano RP. Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Journal of the American Heart Association. 6. PMID 29151034 DOI: 10.1161/Jaha.117.006901  0.303
2017 Cavallari I, Morrow DA, Creager MA, Olin J, Bhatt DL, Steg PG, Storey RF, Cohen M, Scirica BS, Piazza G, Goodrich EL, Braunwald E, Sabatine MS, Bonaca MP. Frequency, Predictors and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients with Symptomatic Atherosclerosis. Circulation. PMID 29084737 DOI: 10.1161/Circulationaha.117.031062  0.32
2017 Fanola CL, Morrow DA, Cannon CP, Jarolim P, Lukas MA, Bode C, Hochman JS, Goodrich EL, Braunwald E, O'Donoghue ML. Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) Trial. Journal of the American Heart Association. 6. PMID 29066436 DOI: 10.1161/Jaha.117.005637  0.346
2017 Fanaroff AC, Roe MT, Clare RM, Lokhnygina Y, Navar AM, Giugliano RP, Wiviott SD, Tershakovec AM, Braunwald E, Blazing MA. Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long-Term Follow-Up After Acute Coronary Syndromes. Journal of the American Heart Association. 6. PMID 28923989 DOI: 10.1161/Jaha.117.005840  0.344
2017 Marian AJ, Braunwald E. Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. Circulation Research. 121: 749-770. PMID 28912181 DOI: 10.1161/Circresaha.117.311059  0.371
2017 Braunwald E. Cardiomyopathies: An Overview. Circulation Research. 121: 711-721. PMID 28912178 DOI: 10.1161/Circresaha.117.311812  0.345
2017 Bonaca MP, Storey RF, Theroux P, Steg PG, Bhatt DL, Cohen MC, Im K, Murphy SA, Magnani G, Ophuis TO, Rudah M, Parkhomenko A, Isaza D, Kamensky G, Goudev A, ... ... Braunwald E, et al. Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54. Journal of the American College of Cardiology. 70: 1368-1375. PMID 28882235 DOI: 10.1016/J.Jacc.2017.07.768  0.365
2017 Braunwald E. An Important Step for Thrombocardiology. The New England Journal of Medicine. 377: 1387-1388. PMID 28844176 DOI: 10.1056/Nejme1710241  0.394
2017 Magnuson EA, Li H, Wang K, Vilain K, Shafiq A, Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Braunwald E, Sabatine MS, Cohen DJ. Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 Trial. Journal of the American College of Cardiology. 70: 527-538. PMID 28750695 DOI: 10.1016/J.Jacc.2017.05.063  0.387
2017 Butler J, Anstrom KJ, Felker GM, Givertz MM, Kalogeropoulos AP, Konstam MA, Mann DL, Margulies KB, McNulty SE, Mentz RJ, Redfield MM, Tang WHW, Whellan DJ, Shah M, Desvigne-Nickens P, ... ... Braunwald E, et al. Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial. Jama Cardiology. PMID 28700781 DOI: 10.1001/Jamacardio.2017.2198  0.357
2017 Eisen A, Ruff CT, Braunwald E, Hamershock RA, Lewis BS, Hassager C, Chao TF, Le Heuzey JY, Mercuri M, Rutman H, Antman EM, Giugliano RP. Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial. Journal of the American Heart Association. 6. PMID 28666993 DOI: 10.1161/Jaha.117.006035  0.372
2017 Snipelisky D, Kelly J, Levine JA, Koepp GA, Anstrom KJ, McNulty SE, Zakeri R, Felker GM, Hernandez AF, Braunwald E, Redfield MM. Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction: Clinical Correlates and Association With Standard Heart Failure Severity Indices. Circulation. Heart Failure. 10: e003878. PMID 28588021 DOI: 10.1161/Circheartfailure.117.003878  0.347
2017 Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Felker GM, Tang WHW, LaRue SJ, Redfield MM, Semigran MJ, Givertz MM, Van Buren P, Whellan D, Anstrom KJ, Shah MR, ... ... Braunwald E, et al. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial. Jama. 317: 1958-1966. PMID 28510680 DOI: 10.1001/Jama.2017.5427  0.338
2017 Pokharel Y, Chinnakondepalli K, Vilain K, Wang K, Mark DB, Davies G, Blazing MA, Giugliano RP, Braunwald E, Cannon CP, Cohen DJ, Magnuson EA. Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation. Cardiovascular Quality and Outcomes. 10. PMID 28506979 DOI: 10.1161/Circoutcomes.116.003201  0.346
2017 Reddy YNV, Lewis GD, Shah SJ, LeWinter M, Semigran M, Davila-Roman VG, Anstrom K, Hernandez A, Braunwald E, Redfield MM, Borlaug BA. INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and Design. Circulation. Heart Failure. 10. PMID 28476756 DOI: 10.1161/Circheartfailure.117.003862  0.391
2017 Ho CY, McMurray JJV, Cirino AL, Colan SD, Day SM, Desai AS, Lipshultz SE, MacRae CA, Shi L, Solomon SD, Orav EJ, Braunwald E. The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial. American Heart Journal. 187: 145-155. PMID 28454798 DOI: 10.1016/J.Ahj.2017.02.008  0.389
2017 De Caterina R, Renda G, Carnicelli AP, Nordio F, Trevisan M, Mercuri MF, Ruff CT, Antman EM, Braunwald E, Giugliano RP. Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial. Journal of the American College of Cardiology. 69: 1372-1382. PMID 28302288 DOI: 10.1016/J.Jacc.2016.12.031  0.327
2017 Bohula EA, Morrow DA, Giugliano RP, Blazing MA, He P, Park JG, Murphy SA, White JA, Kesaniemi YA, Pedersen TR, Brady AJ, Mitchel Y, Cannon CP, Braunwald E. Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention. Journal of the American College of Cardiology. 69: 911-921. PMID 28231942 DOI: 10.1016/J.Jacc.2016.11.070  0.34
2017 AbouEzzeddine OF, McKie PM, Dunlay SM, Stevens SR, Felker GM, Borlaug BA, Chen HH, Tracy RP, Braunwald E, Redfield MM. Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction. Journal of the American Heart Association. 6. PMID 28214792 DOI: 10.1161/Jaha.116.004382  0.336
2017 Link MS, Giugliano RP, Ruff CT, Scirica BM, Huikuri H, Oto A, Crompton AE, Murphy SA, Lanz H, Mercuri MF, Antman EM, Braunwald E. Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48). Circulation. Arrhythmia and Electrophysiology. 10. PMID 28077507 DOI: 10.1161/Circep.116.004267  0.346
2017 Eisen A, Cannon CP, Braunwald E, Steen DL, Zhou J, Goodrich EL, Im K, Dalby AJ, Spinar J, Daga S, Lukas MA, O'Donoghue ML. Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) Trial. Journal of the American Heart Association. 6. PMID 28077384 DOI: 10.1161/Jaha.116.004332  0.375
2017 Eisen A, Bonaca MP, Jarolim P, Scirica BM, White HD, Tendera M, Dellborg M, Nicolau JC, Morais J, Fox KA, Bohula EA, Murphy SA, Braunwald E, Morrow DA. High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial. Clinical Chemistry. 63: 307-315. PMID 28062625 DOI: 10.1373/Clinchem.2016.264788  0.414
2017 Maron BJ, Rowin EJ, Maron MS, Braunwald E. Nonobstructive Hypertrophic Cardiomyopathy Out of the Shadows: Known from the Beginning but Largely Ignored … Until Now. The American Journal of Medicine. 130: 119-123. PMID 27746287 DOI: 10.1016/J.Amjmed.2016.09.015  0.406
2017 Bergmark B, Bhatt D, Steg P, Fanola C, Mosenzon O, Raz I, Braunwald E, Scirica B. BLOOD PRESSURE, SUBCLINICAL MYOCARDIAL INJURY AND CARDIOVASCULAR OUTCOMES AMONG PATIENTS WITH DIABETES AND HIGH CARDIOVASCULAR RISK: OBSERVATIONS FROM THE SAVOR-TIMI 53 TRIAL Journal of the American College of Cardiology. 69: 1653. DOI: 10.1016/S0735-1097(17)35042-8  0.317
2016 Joyce E, Lala A, Stevens SR, Cooper LB, AbouEzzeddine OF, Groarke JD, Grodin JL, Braunwald E, Anstrom KJ, Redfield MM, Stevenson LW. Prevalence, Profile, and Prognosis of Severe Obesity in Contemporary Hospitalized Heart Failure Trial Populations. Jacc. Heart Failure. 4: 923-931. PMID 27908391 DOI: 10.1016/J.Jchf.2016.09.013  0.301
2016 Braunwald E. Treatment of Left Main Coronary Artery Disease. The New England Journal of Medicine. 375: 2284-2285. PMID 27797298 DOI: 10.1056/Nejme1612570  0.383
2016 Bonaca MP, Creager MA, Olin J, Scirica BM, Gilchrist IC, Murphy SA, Goodrich EL, Braunwald E, Morrow DA. Peripheral Revascularization in Patients With Peripheral Artery Disease With Vorapaxar: Insights From the TRA 2°P-TIMI 50 Trial. Jacc. Cardiovascular Interventions. 9: 2157-2164. PMID 27765312 DOI: 10.1016/J.Jcin.2016.07.034  0.33
2016 Ruff CT, Giugliano RP, Braunwald E, Murphy SA, Brown K, Jarolim P, Mercuri M, Antman EM, Morrow DA. Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation: A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial. Jama Cardiology. PMID 27706467 DOI: 10.1001/Jamacardio.2016.3311  0.338
2016 Scirica BM, Bhatt DL, Braunwald E, Raz I, Cavender MA, Im K, Mosenzon O, Udell JA, Hirshberg B, Pollack PS, Steg PG, Jarolim P, Morrow DA. Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk: A Secondary Analysis of a Randomized Clinical Trial. Jama Cardiology. PMID 27681000 DOI: 10.1001/Jamacardio.2016.3030  0.325
2016 Braunwald E, Rutherford JD. Limitation of Infarct Size and the Open Artery Hypothesis: A Conversation With Eugene Braunwald, MD. Circulation. 134: 839-46. PMID 27647297 DOI: 10.1161/Circulationaha.116.024714  0.378
2016 Steffel J, Giugliano RP, Braunwald E, Murphy SA, Mercuri M, Choi Y, Aylward P, White H, Zamorano JL, Antman EM, Ruff CT. Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 Analysis. Journal of the American College of Cardiology. 68: 1169-78. PMID 27609678 DOI: 10.1016/J.Jacc.2016.06.034  0.3
2016 Bonaca MP, Goto S, Bhatt DL, Steg PG, Storey RF, Cohen M, Goodrich E, Mauri L, Ophuis TO, Ruda M, Spinar J, Seung KB, Hu DY, Dalby AJ, Jensen EC, ... ... Braunwald E, et al. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54). Circulation. PMID 27576775 DOI: 10.1161/Circulationaha.116.024637  0.403
2016 Eisen A, Cannon CP, Blazing MA, Bohula EA, Park JG, Murphy SA, White JA, Giugliano RP, Braunwald E. The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial. European Heart Journal. PMID 27569841 DOI: 10.1093/Eurheartj/Ehw377  0.342
2016 Butler J, Hernandez AF, Anstrom KJ, Kalogeropoulos A, Redfield MM, Konstam MA, Tang WH, Felker GM, Shah MR, Braunwald E. Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure. Jacc. Heart Failure. PMID 27522631 DOI: 10.1016/J.Jchf.2016.06.003  0.358
2016 Margulies KB, Hernandez AF, Redfield MM, Givertz MM, Oliveira GH, Cole R, Mann DL, Whellan DJ, Kiernan MS, Felker GM, McNulty SE, Anstrom KJ, Shah MR, Braunwald E, Cappola TP, et al. Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. Jama. 316: 500-508. PMID 27483064 DOI: 10.1001/Jama.2016.10260  0.399
2016 Bohula EA, Bonaca MP, Braunwald E, Aylward PE, Corbalan R, De Ferrari GM, He P, Lewis BS, Merlini PA, Murphy SA, Sabatine MS, Scirica BM, Morrow DA. Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients with Stable Ischemic Heart Disease and Prior Myocardial Infarction. Circulation. PMID 27440003 DOI: 10.1161/Circulationaha.115.019861  0.369
2016 Bonaca MP, Bhatt DL, Oude Ophuis T, Steg PG, Storey R, Cohen M, Kuder J, Im K, Magnani G, Budaj A, Theroux P, Hamm C, Špinar J, Kiss RG, Dalby AJ, ... ... Braunwald E, et al. Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events: A Secondary Analysis of the PEGASUS-TIMI 54 Trial. Jama Cardiology. 1: 425-432. PMID 27438319 DOI: 10.1001/Jamacardio.2016.1017  0.362
2016 Pfeffer MA, Braunwald E. Treatment of Heart Failure With Preserved Ejection Fraction: Reflections on Its Treatment With an Aldosterone Antagonist. Jama Cardiology. 1: 7-8. PMID 27437645 DOI: 10.1001/Jamacardio.2015.0356  0.314
2016 Kidd SK, Bonaca MP, Braunwald E, De Ferrari GM, Lewis BS, Merlini PA, Murphy SA, Scirica BM, White HD, Morrow DA. Universal Classification System Type of Incident Myocardial Infarction in Patients With Stable Atherosclerosis: Observations From Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50. Journal of the American Heart Association. 5. PMID 27431644 DOI: 10.1161/Jaha.116.003237  0.362
2016 Bonaca MP, O'Malley RG, Jarolim P, Scirica BM, Murphy SA, Conrad MJ, Cannon CP, White HD, Braunwald E, Morrow DA, Sabatine MS. Serial Cardiac Troponin Measured Using a High-Sensitivity Assay in Stable Patients With Ischemic Heart Disease. Journal of the American College of Cardiology. 68: 322-3. PMID 27417011 DOI: 10.1016/J.Jacc.2016.04.046  0.416
2016 Eisen A, Ruff CT, Braunwald E, Nordio F, Corbalán R, Dalby A, Dorobantu M, Mercuri M, Lanz H, Rutman H, Wiviott SD, Antman EM, Giugliano RP. Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF-TIMI 48 Trial. Journal of the American Heart Association. 5. PMID 27402235 DOI: 10.1161/Jaha.116.003735  0.344
2016 Rost NS, Giugliano RP, Ruff CT, Murphy SA, Crompton AE, Norden AD, Silverman S, Singhal AB, Nicolau JC, SomaRaju B, Mercuri MF, Antman EM, Braunwald E. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48. Stroke; a Journal of Cerebral Circulation. PMID 27387994 DOI: 10.1161/Strokeaha.116.013540  0.354
2016 Bohula EA, Giugliano RP, Ruff CT, Kuder JF, Murphy SA, Antman EM, Braunwald E. Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial. Circulation. 134: 24-36. PMID 27358434 DOI: 10.1161/Circulationaha.116.022361  0.333
2016 Magnani G, Giugliano RP, Ruff CT, Murphy SA, Nordio F, Metra M, Moccetti T, Mitrovic V, Shi M, Mercuri M, Antman EM, Braunwald E. Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48. European Journal of Heart Failure. PMID 27349698 DOI: 10.1002/Ejhf.595  0.348
2016 Cahn A, Raz I, Mosenzon O, Leibowitz G, Yanuv I, Rozenberg A, Iqbal N, Hirshberg B, Sjostrand M, Stahre C, Im K, Kanevsky E, Scirica BM, Bhatt DL, Braunwald E. Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial. Diabetes Care. PMID 27222508 DOI: 10.2337/Dc15-2763  0.321
2016 Kato ET, Giugliano RP, Ruff CT, Koretsune Y, Yamashita T, Kiss RG, Nordio F, Murphy SA, Kimura T, Jin J, Lanz H, Mercuri M, Braunwald E, Antman EM. Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial. Journal of the American Heart Association. 5. PMID 27207971 DOI: 10.1161/Jaha.116.003432  0.326
2016 Lewis GD, Semigran MJ, Givertz MM, Malhotra R, Anstrom KJ, Hernandez AF, Shah MR, Braunwald E. Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure. Circulation. Heart Failure. 9. PMID 27140203 DOI: 10.1161/Circheartfailure.115.000345  0.31
2016 Gupta DK, Giugliano RP, Ruff CT, Claggett B, Murphy S, Antman E, Mercuri MF, Braunwald E, Solomon SD. The Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic Substudy. Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography. PMID 27106009 DOI: 10.1016/J.Echo.2016.03.004  0.322
2016 Kosova EC, Bonaca MP, Dellborg M, He P, Morais J, Oude Ophuis T, Scirica BM, Tendera M, Theroux P, Braunwald E, Morrow DA. Vorapaxar in patients with coronary artery bypass grafting: Findings from the TRA 2°P-TIMI 50 trial. European Heart Journal. Acute Cardiovascular Care. PMID 27075924 DOI: 10.1177/2048872616644910  0.402
2016 Kloner RA, Braunwald E. Intravenous Beta-Blockade for Limiting Myocardial Infarct Size: Rejuvenation of a Concept. Journal of the American College of Cardiology. 67: 2105-2107. PMID 27052689 DOI: 10.1016/J.Jacc.2016.02.061  0.32
2016 Bonaca MP, Bhatt DL, Storey RF, Steg PG, Cohen M, Kuder J, Goodrich E, Nicolau JC, Parkhomenko A, López-Sendón J, Dellborg M, Dalby A, Špinar J, Aylward P, Corbalán R, ... ... Braunwald E, et al. Efficacy and Safety of Ticagrelor as Long-Term Secondary Prevention in Patients with Peripheral Artery Disease and Prior Myocardial Infarction. Journal of the American College of Cardiology. PMID 27046162 DOI: 10.1016/J.Jacc.2016.03.524  0.416
2016 Bhatt DL, Bonaca MP, Bansilal S, Angiolillo DJ, Cohen M, Storey RF, Im K, Murphy SA, Held P, Braunwald E, Sabatine MS, Steg PG. Reduction in Ischemic Events with Ticagrelor in Diabetic Patients: From the PEGASUS-TIMI 54 Trial. Journal of the American College of Cardiology. PMID 27046160 DOI: 10.1016/J.Jacc.2016.03.529  0.35
2016 Giugliano RP, Ruff CT, Wiviott SD, Nordio F, Murphy SA, Kappelhof JA, Shi M, Mercuri M, Antman EM, Braunwald E. Mortality in Patients With Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial. The American Journal of Medicine. PMID 26994510 DOI: 10.1016/J.Amjmed.2016.02.028  0.346
2016 Storey RF, Angiolillo DJ, Bonaca MP, Thomas MR, Judge HM, Rollini F, Franchi F, Ahsan AJ, Bhatt DL, Kuder JF, Steg PG, Cohen M, Muthusamy R, Braunwald E, Sabatine MS. Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial. Journal of the American College of Cardiology. 67: 1145-54. PMID 26965534 DOI: 10.1016/J.Jacc.2015.12.062  0.357
2016 Braunwald E. Academic-industrial collaboration in the development of the first angiotensin receptor blocker: neprilysin inhibitor in the treatment of heart failure European Heart Journal. 37: 745-746. PMID 26933120 DOI: 10.1093/Eurheartj/Ehw055  0.337
2016 Xu H, Ruff CT, Giugliano RP, Murphy SA, Nordio F, Patel I, Shi M, Mercuri M, Antman EM, Braunwald E. Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF-TIMI48 Trial. Journal of the American Heart Association. 5. PMID 26908401 DOI: 10.1161/Jaha.115.002587  0.307
2016 Berg DD, Bonaca MP, Braunwald E, Corbalan R, Goto S, Kiss RG, Murphy SA, Scirica BM, Spinar J, Morrow DA. Outcomes in Stable Patients With Previous Atherothrombotic Events Receiving Vorapaxar Who Experience a New Acute Coronary Event (from TRA2°P-TIMI 50). The American Journal of Cardiology. PMID 26876014 DOI: 10.1016/J.Amjcard.2015.12.052  0.399
2016 Eisen A, Giugliano RP, Ruff CT, Nordio F, Gogia HS, Awasty VR, Henderson DA, Mercuri MF, Rutman H, Antman EM, Braunwald E. Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48) trial. American Heart Journal. 172: 144-51. PMID 26856226 DOI: 10.1016/J.Ahj.2015.11.004  0.335
2016 Bonaca MP, Gutierrez JA, Creager MA, Scirica BM, Olin J, Murphy SA, Braunwald E, Morrow DA. Acute Limb Ischemia and Outcomes With Vorapaxar in Patients with Peripheral Artery Disease: Results From TRA2°P-TIMI 50. Circulation. PMID 26826179 DOI: 10.1161/Circulationaha.115.019355  0.352
2016 Murphy SA, Cannon CP, Blazing MA, Giugliano RP, White JA, Lokhnygina Y, Reist C, Im K, Bohula EA, Isaza D, Lopez-Sendon J, Dellborg M, Kher U, Tershakovec AM, Braunwald E. Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial. Journal of the American College of Cardiology. 67: 353-61. PMID 26821621 DOI: 10.1016/J.Jacc.2015.10.077  0.342
2016 Braunwald E. The path to an angiotensin receptor antagonist-neprilysin inhibitor in the treatment of heart failure. Journal of the American College of Cardiology. 65: 1029-41. PMID 25766951 DOI: 10.1016/J.Jacc.2015.01.033  0.318
2016 Bonaca MP, Bhatt D, Storey R, Steg P, Cohen M, Kuder J, Im K, Held P, Jensen E, Braunwald E, Sabatine M. EFFICACY AND SAFETY OF TICAGRELOR AS LONG-TERM SECONDARY PREVENTION IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION AND PERIPHERAL ARTERY DISEASE Journal of the American College of Cardiology. 67: 2266. DOI: 10.1016/S0735-1097(16)32267-7  0.345
2016 Cunningham J, Giugliano R, Braunwald E, Trevisan M, Nordio F, Ophuis TO, Bergovec M, Mercuri M, Ruff C, Bonaca M. EDOXABAN VERSUS WARFARIN IN 841 PATIENTS WITH ATRIAL FIBRILLATION AND PERIPHERAL ARTERIAL DISEASE: INSIGHTS FROM THE ENGAGE AF-TIMI 48 TRIAL Journal of the American College of Cardiology. 67: 2262. DOI: 10.1016/S0735-1097(16)32263-X  0.308
2016 Bansilal S, Bonaca M, Cornel J, Storey R, Bhatt D, Steg P, Im K, Held P, Jensen E, Braunwald E, Sabatine M, Ophuis TO. EFFICACY AND SAFETY OF TICAGRELOR FOR LONG-TERM SECONDARY PREVENTION OF ATHEROTHROMBOTIC EVENTS IN PATIENTS WITH PRIOR MI AND MULTIVESSEL CORONARY DISEASE: INSIGHTS FROM THE PEGASUS-TIMI 54 TRIAL Journal of the American College of Cardiology. 67: 2146. DOI: 10.1016/S0735-1097(16)32147-7  0.36
2016 Eisen A, Bonaca M, Scirica B, Bohula E, Murphy S, Braunwald E, Morrow D. BLEEDING IN STABLE PATIENTS WITH ATHEROSCLEROTIC DISEASE: INSIGHTS FROM TRA2°P- TIMI 50 TRIAL Journal of the American College of Cardiology. 67: 2139. DOI: 10.1016/S0735-1097(16)32140-4  0.339
2016 May EAB, Morrow D, Cannon C, Giugliano R, Blazing M, He P, Murphy S, Jennifer W, Kesaniemi A, Pedersen T, Brady AJ, Mitchel YB, Tershakovec A, Braunwald E. ATHEROTHROMBOTIC RISK STRATIFICATION AND EZETIMIBE USE IN IMPROVE-IT Journal of the American College of Cardiology. 67: 2129. DOI: 10.1016/S0735-1097(16)32130-1  0.347
2016 Eisen A, Ruff C, Nordio F, Corbalan R, Dalby A, Dorobantu M, Mercuri M, Lanz H, Rutman H, Antman E, Braunwald E, Giugliano R. SUDDEN CARDIAC DEATH IN 21,105 PATIENTS WITH ATRIAL FIBRILLATION: INSIGHTS FROM THE ENGAGE AF- TIMI 48 TRIAL Journal of the American College of Cardiology. 67: 789. DOI: 10.1016/S0735-1097(16)30790-2  0.333
2016 Cavallari I, Cannon C, Braunwald E, Goodrich E, Im K, Lukas MA, O'Donoghue M. METABOLIC SYNDROME AND THE RISK OF ADVERSE CARDIOVASCULAR EVENTS AFTER AN ACUTE CORONARY SYNDROME: INSIGHTS FROM SOLID-TIMI 52 TRIAL Journal of the American College of Cardiology. 67: 448. DOI: 10.1016/S0735-1097(16)30449-1  0.316
2015 Braunwald E. Cardiovascular pharmacology: a look back and a glimpse into the future. European Heart Journal. Cardiovascular Pharmacotherapy. 1: 7-9. PMID 27533957 DOI: 10.1093/Ehjcvp/Pvu002  0.313
2015 Redfield MM, Anstrom KJ, Levine JA, Koepp GA, Borlaug BA, Chen HH, LeWinter MM, Joseph SM, Shah SJ, Semigran MJ, Felker GM, Cole RT, Reeves GR, Tedford RJ, Tang WH, ... ... Braunwald E, et al. Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. The New England Journal of Medicine. PMID 26549714 DOI: 10.1056/Nejmoa1510774  0.321
2015 Cavender MA, Scirica BM, Raz I, Steg PG, McGuire DK, Leiter LA, Hirshberg B, Davidson J, Cahn A, Mosenzon O, Im K, Braunwald E, Bhatt DL. Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c. The American Journal of Medicine. PMID 26524706 DOI: 10.1016/J.Amjmed.2015.09.022  0.398
2015 Bonaca MP, Bhatt DL, Steg PG, Storey RF, Cohen M, Im K, Oude Ophuis T, Budaj A, Goto S, López-Sendón J, Diaz R, Dalby A, Van de Werf F, Ardissino D, Montalescot G, ... ... Braunwald E, et al. Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54. European Heart Journal. PMID 26491109 DOI: 10.1093/Eurheartj/Ehv531  0.339
2015 Magnani G, Storey RF, Steg G, Bhatt DL, Cohen M, Kuder J, Im K, Aylward P, Ardissino D, Isaza D, Parkhomenko A, Goudev AR, Dellborg M, Kontny F, Corbalan R, ... ... Braunwald E, et al. Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial. European Heart Journal. PMID 26443023 DOI: 10.1093/Eurheartj/Ehv482  0.305
2015 Geller BJ, Giugliano RP, Braunwald E, Murphy SA, Hanyok JJ, Jin J, Mercuri M, Antman EM, Ruff CT. Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: Results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction Study 48 trial. American Heart Journal. 170: 669-74. PMID 26386790 DOI: 10.1016/J.Ahj.2015.06.020  0.331
2015 Braunwald E. Another step toward personalized care of patients with heart failure. European Journal of Heart Failure. 17: 988-90. PMID 26377433 DOI: 10.1002/Ejhf.348  0.316
2015 Bohula EA, Aylward PE, Bonaca MP, Corbalan RL, Kiss RG, Murphy SA, Scirica BM, White H, Braunwald E, Morrow DA. The Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients with Prior Myocardial Infarction and no History of Stroke or TIA: Results from TRA 2°P-TIMI 50. Circulation. PMID 26338971 DOI: 10.1161/Circulationaha.114.015042  0.362
2015 Udell JA, Bonaca MP, Collet JP, Lincoff AM, Kereiakes DJ, Costa F, Lee CW, Mauri L, Valgimigli M, Park SJ, Montalescot G, Sabatine MS, Braunwald E, Bhatt DL. Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials. European Heart Journal. PMID 26324537 DOI: 10.1093/Eurheartj/Ehv443  0.375
2015 Scirica BM, Braunwald E, Raz I, Cavender MA, Morrow DA, Jarolim P, Udell JA, Mosenzon O, Im K, Umez-Eronini AA, Pollack PS, Hirshberg B, Frederich R, Lewis BS, McGuire DK, et al. Response to Letter Regarding Article, "Heart Failure, Saxagliptin and Diabetes Mellitus: Observations From the SAVOR-TIMI 53 Randomized Trial". Circulation. 132: e121-2. PMID 26260506 DOI: 10.1161/Circulationaha.115.015511  0.363
2015 Braunwald E. Progress in the Noninvasive Detection of High-Risk Coronary Plaques Journal of the American College of Cardiology. 66: 347-349. PMID 26205590 DOI: 10.1016/J.Jacc.2015.05.067  0.364
2015 Morrow AG, Oldham HN, Callard GM, Braunwald E. The assessment of operative results in congenital heart disease by intraoperative indicator-dilution curves. Circulation. 33: 263-9. PMID 25823099 DOI: 10.1161/01.Cir.33.2.263  0.306
2015 Magnani G, Bonaca MP, Braunwald E, Dalby AJ, Fox KA, Murphy SA, Nicolau JC, Oude Ophuis T, Scirica BM, Spinar J, Theroux P, Morrow DA. Efficacy and safety of vorapaxar as approved for clinical use in the United States. Journal of the American Heart Association. 4: e001505. PMID 25792124 DOI: 10.1161/Jaha.114.001505  0.363
2015 Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, ... ... Braunwald E, et al. Long-term use of ticagrelor in patients with prior myocardial infarction. The New England Journal of Medicine. 372: 1791-800. PMID 25773268 DOI: 10.1056/Nejmoa1500857  0.388
2015 Leiter LA, Teoh H, Braunwald E, Mosenzon O, Cahn A, Kumar KM, Smahelova A, Hirshberg B, Stahre C, Frederich R, Bonnici F, Scirica BM, Bhatt DL, Raz I. Efficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 Trial. Diabetes Care. 38: 1145-53. PMID 25758769 DOI: 10.2337/Dc14-2868  0.317
2015 Mega JL, Stitziel NO, Smith JG, Chasman DI, Caulfield MJ, Devlin JJ, Nordio F, Hyde CL, Cannon CP, Sacks FM, Poulter NR, Sever PS, Ridker PM, Braunwald E, Melander O, et al. Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. Lancet (London, England). 385: 2264-71. PMID 25748612 DOI: 10.1016/S0140-6736(14)61730-X  0.344
2015 AbouEzzeddine OF, Haines P, Stevens S, Nativi-Nicolau J, Felker GM, Borlaug BA, Chen HH, Tracy RP, Braunwald E, Redfield MM. Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure). Jacc. Heart Failure. 3: 245-52. PMID 25742762 DOI: 10.1016/J.Jchf.2014.10.009  0.364
2015 Grinstein J, Bonaca MP, Jarolim P, Conrad MJ, Bohula-May E, Deenadayalu N, Braunwald E, Giugliano RP, Newby LK, Sabatine MS, Morrow DA. Prognostic implications of low level cardiac troponin elevation using high-sensitivity cardiac troponin T. Clinical Cardiology. 38: 230-5. PMID 25737394 DOI: 10.1002/Clc.22379  0.372
2015 O'Donoghue ML, Ruff CT, Giugliano RP, Murphy SA, Grip LT, Mercuri MF, Rutman H, Shi M, Kania G, Cermak O, Braunwald E, Antman EM. Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation†. European Heart Journal. 36: 1470-7. PMID 25687352 DOI: 10.1093/Eurheartj/Ehv014  0.302
2015 Cavender MA, Scirica BM, Bonaca MP, Angiolillo DJ, Dalby AJ, Dellborg M, Morais J, Murphy SA, Ophuis TO, Tendera M, Braunwald E, Morrow DA. Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trial. Circulation. 131: 1047-53. PMID 25681464 DOI: 10.1161/Circulationaha.114.013774  0.37
2015 Udell JA, Bhatt DL, Braunwald E, Cavender MA, Mosenzon O, Steg PG, Davidson JA, Nicolau JC, Corbalan R, Hirshberg B, Frederich R, Im K, Umez-Eronini AA, He P, McGuire DK, et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial. Diabetes Care. 38: 696-705. PMID 25552421 DOI: 10.2337/Dc14-1850  0.313
2015 Mentz RJ, Stevens SR, DeVore AD, Lala A, Vader JM, AbouEzzeddine OF, Khazanie P, Redfield MM, Stevenson LW, O'Connor CM, Goldsmith SR, Bart BA, Anstrom KJ, Hernandez AF, Braunwald E, et al. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure. Jacc. Heart Failure. 3: 97-107. PMID 25543972 DOI: 10.1016/j.jchf.2014.09.003  0.323
2015 Scirica BM, Belardinelli L, Chaitman BR, Waks JW, Volo S, Karwatowska-Prokopczuk E, Murphy SA, Cheng ML, Braunwald E, Morrow DA. Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 17: 32-7. PMID 25210025 DOI: 10.1093/Europace/Euu217  0.345
2015 Gutierrez A, Bonaca M, Scirica B, Creager M, Murphy S, Braunwald E, Morrow D. VORAPAXAR AND ACUTE LIMB ISCHEMIA: INSIGHTS FROM THE THROMBIN RECEPTOR ANTAGONIST IN SECONDARY PREVENTION OF ATHEROTHROMBOTIC ISCHEMIC EVENTS-TIMI 50 TRIAL Journal of the American College of Cardiology. 65: A2047. DOI: 10.1016/S0735-1097(15)62047-2  0.31
2015 Gilchrist I, Bonaca M, Scirica B, Creager M, Murphy S, Braunwald E, Morrow D. VORAPAXAR AND PERIPHERAL REVASCULARIZATION: INSIGHTS FOM THE TRA2P-TIMI 50 TRIAL Journal of the American College of Cardiology. 65: A2044. DOI: 10.1016/S0735-1097(15)62044-7  0.305
2015 Gilchrist I, Morrow D, Scirica B, Creager M, Bhatt D, He P, Murphy S, Braunwald E, Bonaca M. STATIN INTENSITY AND OUTCOME IN PATIENTS WITH PERIPHERAL ARTERY DISEASE: INSIGHTS FROM THE TRA2P-TIMI 50 TRIAL Journal of the American College of Cardiology. 65: A2043. DOI: 10.1016/S0735-1097(15)62043-5  0.322
2015 Kosova E, Scirica B, Bonaca M, Murphy S, Braunwald E, Morrow D. THE ROLE OF VORAPAXAR IN PATIENTS WITH CORONARY ARTERY BYPASS GRAFTING: FINDINGS FROM THE TRA 2P-TIMI 50 TRIAL Journal of the American College of Cardiology. 65: A1588. DOI: 10.1016/S0735-1097(15)61588-1  0.394
2015 Magnani G, O’Donoghue M, Braunwald E, Steen D, Jarolim P, Lukas MA, White H, Lewis B, Winter Rd, Zhou J, Im K, Cannon C, Morrow D. Galectin-3 For Heart Failure Risk Stratification In Patients After Acute Coronary Syndromes (Acs): Insights From The Solid-Timi 52 Trial Journal of the American College of Cardiology. 65. DOI: 10.1016/S0735-1097(15)60773-2  0.387
2015 Bonaca MP, Bhatt DL, Steg PG, Budaj A, Bansilal S, Storey RF, Im K, Magnani G, Ophuis TO, Ruda M, Hamm C, Spinar J, Kiss RG, Diaz R, Van de Werf FJ, ... ... Braunwald E, et al. TCT-78 Efficacy of Long-Term Ticagrelor in Stented Patients in PEGASUS-TIMI 54 Journal of the American College of Cardiology. 66: B36. DOI: 10.1016/J.Jacc.2015.08.121  0.313
2014 Bonaca MP, O'Malley RG, Murphy SA, Jarolim P, Conrad MJ, Braunwald E, Sabatine MS, Morrow DA. Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: Analysis from MERLIN-TIMI 36. European Heart Journal. Acute Cardiovascular Care. PMID 25538086 DOI: 10.1177/2048872614564081  0.378
2014 Braunwald E. The war against heart failure: the Lancet lecture. Lancet (London, England). 385: 812-24. PMID 25467564 DOI: 10.1016/S0140-6736(14)61889-4  0.38
2014 Bonaca MP, Scirica BM, Braunwald E, Wiviott SD, Goto S, Nilsen DW, Bonarjee V, Murphy SA, Morrow DA. New ischemic stroke and outcomes with vorapaxar versus placebo: results from the TRA 2 °P-TIMI 50 trial. Journal of the American College of Cardiology. 64: 2318-26. PMID 25465417 DOI: 10.1016/J.Jacc.2014.07.997  0.364
2014 Bonaca MP, Scirica BM, Braunwald E, Wiviott SD, O'Donoghue ML, Murphy SA, Morrow DA. Coronary stent thrombosis with vorapaxar versus placebo: results from the TRA 2° P-TIMI 50 trial. Journal of the American College of Cardiology. 64: 2309-17. PMID 25465416 DOI: 10.1016/J.Jacc.2014.09.037  0.33
2014 Cavender MA, Gibson CM, Braunwald E, Wiviott SD, Murphy SA, Toda Kato E, Plotnikov AN, Amuchástegui M, Oude Ophuis T, van Hessen M, Mega JL. The effect of rivaroxaban on myocardial infarction in the ATLAS ACS 2 - TIMI 51 trial. European Heart Journal. Acute Cardiovascular Care. PMID 25318481 DOI: 10.1177/2048872614554109  0.415
2014 Scirica BM, Braunwald E, Raz I, Cavender MA, Morrow DA, Jarolim P, Udell JA, Mosenzon O, Im K, Umez-Eronini AA, Pollack PS, Hirshberg B, Frederich R, Lewis BS, McGuire DK, et al. Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial. Circulation. 130: 1579-88. PMID 25189213 DOI: 10.1161/Circulationaha.114.010389  0.303
2014 Butler J, Braunwald E, Gheorghiade M. Recognizing worsening chronic heart failure as an entity and an end point in clinical trials. Jama. 312: 789-90. PMID 25157719 DOI: 10.1001/Jama.2014.6643  0.328
2014 Ruff CT, Giugliano RP, Braunwald E, Mercuri M, Curt V, Betcher J, Grip L, Cange AL, Crompton AE, Murphy SA, Deenadayalu N, Antman EM. Transition of patients from blinded study drug to open-label anticoagulation: the ENGAGE AF-TIMI 48 trial. Journal of the American College of Cardiology. 64: 576-84. PMID 25104527 DOI: 10.1016/J.Jacc.2014.05.028  0.314
2014 Blazing MA, Giugliano RP, Cannon CP, Musliner TA, Tershakovec AM, White JA, Reist C, McCagg A, Braunwald E, Califf RM. Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population. American Heart Journal. 168: 205-12.e1. PMID 25066560 DOI: 10.1016/J.Ahj.2014.05.004  0.346
2014 Margulies KB, Anstrom KJ, Hernandez AF, Redfield MM, Shah MR, Braunwald E, Cappola TP. GLP-1 agonist therapy for advanced heart failure with reduced ejection fraction: design and rationale for the functional impact of GLP-1 for heart failure treatment study. Circulation. Heart Failure. 7: 673-9. PMID 25028349 DOI: 10.1161/Circheartfailure.114.000346  0.35
2014 Braunwald E. The ten advances that have defined modern cardiology. Trends in Cardiovascular Medicine. 24: 179-83. PMID 25017918 DOI: 10.1016/J.Tcm.2014.05.005  0.384
2014 Udell JA, Braunwald E, Antman EM, Antman EM, Murphy SA, Montalescot G, Wiviott SD. Prasugrel versus clopidogrel in patients with ST-segment elevation myocardial infarction according to timing of percutaneous coronary intervention: a TRITON-TIMI 38 subgroup analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38). Jacc. Cardiovascular Interventions. 7: 604-12. PMID 24947719 DOI: 10.1016/J.Jcin.2014.01.160  0.37
2014 Giugliano RP, Ruff CT, Rost NS, Silverman S, Wiviott SD, Lowe C, Deenadayalu N, Murphy SA, Grip LT, Betcher JM, Duggal A, Dave J, Shi M, Mercuri M, Antman EM, ... Braunwald E, et al. Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48. Stroke; a Journal of Cerebral Circulation. 45: 2372-8. PMID 24947287 DOI: 10.1161/Strokeaha.114.006025  0.346
2014 Mohammed SF, Borlaug BA, McNulty S, Lewis GD, Lin G, Zakeri R, Semigran MJ, LeWinter M, Hernandez AF, Braunwald E, Redfield MM. Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Circulation. Heart Failure. 7: 580-9. PMID 24833648 DOI: 10.1161/Circheartfailure.114.001192  0.33
2014 Udell JA, Morrow DA, Jarolim P, Sloan S, Hoffman EB, O'Donnell TF, Vora AN, Omland T, Solomon SD, Pfeffer MA, Braunwald E, Sabatine MS. Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease Journal of the American College of Cardiology. 63: 2421-2428. PMID 24727254 DOI: 10.1016/J.Jacc.2014.03.026  0.324
2014 Braunwald E. Responsiveness to loop diuretics in heart failure. European Heart Journal. 35: 1235-7. PMID 24685713 DOI: 10.1093/Eurheartj/Ehu121  0.362
2014 Bonaca MP, Bhatt DL, Braunwald E, Cohen M, Steg PG, Storey RF, Held P, Jensen EC, Sabatine MS. Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial. American Heart Journal. 167: 437-444.e5. PMID 24655690 DOI: 10.1016/J.Ahj.2013.12.020  0.408
2014 Kunadian V, Giugliano RP, Newby LK, Zorkun C, Guo J, Bagai A, Montalescot G, Braunwald E, Califf RM, Van de Werf F, Armstrong PW, Harrington R, Gibson CM. Angiographic outcomes with early eptifibatide therapy in non-ST-segment elevation acute coronary syndrome (from the EARLY ACS Trial). The American Journal of Cardiology. 113: 1297-305. PMID 24607027 DOI: 10.1016/J.Amjcard.2014.01.404  0.389
2014 O'Malley RG, Bonaca MP, Scirica BM, Murphy SA, Jarolim P, Sabatine MS, Braunwald E, Morrow DA. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36). Journal of the American College of Cardiology. 63: 1644-53. PMID 24530676 DOI: 10.1016/J.Jacc.2013.12.034  0.411
2014 Giugliano RP, Braunwald E. The year in acute coronary syndrome. Journal of the American College of Cardiology. 63: 201-214. PMID 24239661 DOI: 10.1016/J.Jacc.2013.10.041  0.353
2014 Zakeri R, Borlaug BA, McNulty SE, Mohammed SF, Lewis GD, Semigran MJ, Deswal A, LeWinter M, Hernandez AF, Braunwald E, Redfield MM. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Circulation. Heart Failure. 7: 123-30. PMID 24162898 DOI: 10.1161/Circheartfailure.113.000568  0.337
2014 Kohli P, Udell JA, Murphy SA, Cannon CP, Antman EM, Braunwald E, Wiviott SD. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38). Journal of the American College of Cardiology. 63: 225-32. PMID 24140678 DOI: 10.1016/J.Jacc.2013.09.023  0.357
2014 Mega JL, Braunwald E, Murphy SA, Plotnikov AN, Burton P, Kiss RG, Parkhomenko A, Tendera M, Widimsky P, Gibson CM. RIVAROXABAN IN PATIENTS STABILIZED AFTER A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION. RESULTS FROM THE ATLAS ACS-2–TIMI-51 TRIAL Rational Pharmacotherapy in Cardiology. 10: 245-252. DOI: 10.20996/1819-6446-2014-10-2-245-252  0.382
2014 May EAB, Bonaca MP, Jarolim P, Antman EM, Braunwald E, Giugliano RP, Newby LK, Sabatine MS, Morrow DA. Prognostic performance of a high-sensitivity cardiac troponin i assay in patients with Non-ST-Elevation acute coronary syndrome Clinical Chemistry. 60: 158-164. DOI: 10.1373/Clinchem.2013.206441  0.39
2014 Kidd S, Bonaca M, Scirica B, Murphy S, Braunwald E, Morrow D. UNIVERSAL CLASSIFICATION SYSTEM TYPE OF INCIDENT MYOCARDIAL INFARCTION IN PATIENTS WITH STABLE ATHEROSCLEROSIS: OBSERVATIONS FROM TRA 2°P-TIMI 50 Journal of the American College of Cardiology. 63: A1568. DOI: 10.1016/S0735-1097(14)61571-0  0.38
2014 Scirica B, Bhatt D, Braunwald E, Raz I, Steg P, Davidson J, Cavender M, Hirshberg B, Umez-Eronini A, Im K, Jarolim P, Morrow D. PROGNOSTIC IMPLICATIONS OF SIMULTANEOUS BIOMARKER ASSESSMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: OBSERVATIONS FROM THE SAVOR-TIMI 53 TRIAL Journal of the American College of Cardiology. 63: A1550. DOI: 10.1016/S0735-1097(14)61553-9  0.319
2014 Kato ET, Bonaca M, Morrow D, Jarolim P, Sloan S, Solomon S, Braunwald E, Sabatine M. GROWTH DIFFERENTIATION FACTOR-15 (GDF-15) AND THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE Journal of the American College of Cardiology. 63: A1525. DOI: 10.1016/S0735-1097(14)61528-X  0.345
2014 Chen HH, Anstrom KJ, Stevens SR, Deswal A, Felker G, Givertz MM, Bart BA, Wilson Tang W, McNulty SE, Velazquez EJ, Lee KL, Borlaug BA, Shah MR, Hernandez AF, Braunwald E, et al. Differential Response to Low Dose Dopamine or Nesiritide in Patients with Acute Heart Failure and Renal Dysfunction in Accordance to LV EF: Sub-Group Analysis of the ROSE AHF Trial Journal of Cardiac Failure. 20: S94. DOI: 10.1016/J.Cardfail.2014.06.264  0.342
2013 Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, Bart BA, Bull DA, Stehlik J, LeWinter MM, Konstam MA, Huggins GS, Rouleau JL, O'Meara E, Tang WH, ... ... Braunwald E, et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. Jama. 310: 2533-43. PMID 24247300 DOI: 10.1001/Jama.2013.282190  0.314
2013 Mogabgab O, Wiviott SD, Cannon CP, Sloan S, Sabatine MS, Antman EM, Braunwald E, Giugliano RP. Circadian variation of stent thrombosis and the effect of more robust platelet inhibition: a post hoc analysis of the TRITON-TIMI 38 trial. Journal of Cardiovascular Pharmacology and Therapeutics. 18: 555-9. PMID 24064010 DOI: 10.1177/1074248413497534  0.324
2013 Braunwald E. The treatment of acute myocardial infarction: the Past, the Present, and the Future. European Heart Journal. Acute Cardiovascular Care. 1: 9-12. PMID 24062883 DOI: 10.1177/2048872612438026  0.36
2013 Braunwald E. Heart failure: an update. Clinical Pharmacology and Therapeutics. 94: 430-2. PMID 24048236 DOI: 10.1038/Clpt.2013.149  0.326
2013 Chen HH, AbouEzzeddine OF, Anstrom KJ, Givertz MM, Bart BA, Felker GM, Hernandez AF, Lee KL, Braunwald E, Redfield MM. Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial. Circulation. Heart Failure. 6: 1087-94. PMID 24046475 DOI: 10.1161/Circheartfailure.113.000347  0.316
2013 Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. The New England Journal of Medicine. 369: 1317-26. PMID 23992601 DOI: 10.1056/Nejmoa1307684  0.326
2013 Braunwald E. Research advances in heart failure: a compendium. Circulation Research. 113: 633-45. PMID 23888056 DOI: 10.1161/Circresaha.113.302254  0.375
2013 Givertz MM, Mann DL, Lee KL, Ibarra JC, Velazquez EJ, Hernandez AF, Mascette AM, Braunwald E. Xanthine oxidase inhibition for hyperuricemic heart failure patients: design and rationale of the EXACT-HF study. Circulation. Heart Failure. 6: 862-8. PMID 23861505 DOI: 10.1161/Circheartfailure.113.000394  0.353
2013 Braunwald E, Morrow DA. Unstable angina is it time for a requiem? Circulation. 127: 2452-2456. PMID 23775194 DOI: 10.1161/Circulationaha.113.001258  0.405
2013 Mega JL, Braunwald E, Wiviott SD, Murphy SA, Plotnikov A, Gotcheva N, Ruda M, Gibson CM. Comparison of the efficacy and safety of two rivaroxaban doses in acute coronary syndrome (from ATLAS ACS 2-TIMI 51). The American Journal of Cardiology. 112: 472-8. PMID 23711804 DOI: 10.1016/J.Amjcard.2013.04.011  0.37
2013 Giraldez RR, Clare RM, Lopes RD, Dalby AJ, Prabhakaran D, Brogan GX, Giugliano RP, James SK, Tanguay JF, Pollack CV, Harrington RA, Braunwald E, Newby LK. Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome. American Heart Journal. 165: 918-925.e2. PMID 23708162 DOI: 10.1016/J.Ahj.2013.01.005  0.348
2013 Tricoci P, Leonardi S, White J, White HD, Armstrong PW, Montalescot G, Giugliano RP, Gibson CM, Van de Werf F, Califf RM, Harrington RA, Braunwald E, Mahaffey KW, Newby LK. Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends. Journal of the American College of Cardiology. 62: 242-51. PMID 23684676 DOI: 10.1016/J.Jacc.2013.04.043  0.393
2013 Gibson CM, Chakrabarti AK, Mega J, Bode C, Bassand JP, Verheugt FW, Bhatt DL, Goto S, Cohen M, Mohanavelu S, Burton P, Stone G, Braunwald E. Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51. Journal of the American College of Cardiology. 62: 286-90. PMID 23602776 DOI: 10.1016/J.Jacc.2013.03.041  0.373
2013 Lopes RD, White JA, Atar D, Keltai M, Kleiman NS, White HD, Widimsky P, Zeymer U, Giugliano RP, Tricoci P, Braunwald E, Bode C, Ohman EM, Armstrong PW, Newby LK. Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes. International Journal of Cardiology. 168: 2510-7. PMID 23578889 DOI: 10.1016/J.Ijcard.2013.03.037  0.369
2013 Amin ST, Morrow DA, Braunwald E, Sloan S, Contant C, Murphy S, Antman EM. Dynamic TIMI risk score for STEMI Journal of the American Heart Association. 2. PMID 23525425 DOI: 10.1161/Jaha.112.003269  0.301
2013 Udell JA, Morrow DA, Braunwald E, Swedberg K, Bode C, Rifai N, Brunel PC, Prescott MF, Ren F, Hoffman EB, Scirica BM. Inhibition of the renin-angiotensin system reduces the rise in serum aldosterone in acute coronary syndrome patients with preserved left ventricular function: observations from the AVANT GARDE-TIMI 43 trial. Clinical Chemistry. 59: 959-67. PMID 23509108 DOI: 10.1373/Clinchem.2012.199729  0.413
2013 Bonaca MP, Scirica BM, Creager MA, Olin J, Bounameaux H, Dellborg M, Lamp JM, Murphy SA, Braunwald E, Morrow DA. Vorapaxar in patients with peripheral artery disease results from TRA2°P-TIMI 50 Circulation. 127: 1522-1529. PMID 23501976 DOI: 10.1161/Circulationaha.112.000679  0.31
2013 Mega JL, Braunwald E, Murphy SA, Plotnikov AN, Burton P, Kiss RG, Parkhomenko A, Tendera M, Widimsky P, Gibson CM. Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51). Journal of the American College of Cardiology. 61: 1853-9. PMID 23500262 DOI: 10.1016/J.Jacc.2013.01.066  0.403
2013 Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, Deswal A, Stevenson LW, Givertz MM, Ofili EO, O'Connor CM, ... ... Braunwald E, et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. Jama. 309: 1268-77. PMID 23478662 DOI: 10.1001/Jama.2013.2024  0.332
2013 Omland T, Pfeffer MA, Solomon SD, de Lemos JA, Røsjø H, Å altytÄ— Benth J, Maggioni A, Domanski MJ, Rouleau JL, Sabatine MS, Braunwald E. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. Journal of the American College of Cardiology. 61: 1240-9. PMID 23414791 DOI: 10.1016/J.Jacc.2012.12.026  0.384
2013 Braunwald E. Cardiovascular science: opportunities for translating research into improved care. The Journal of Clinical Investigation. 123: 6-10. PMID 23281404 DOI: 10.1172/Jci67541  0.39
2013 Kociol RD, McNulty SE, Hernandez AF, Lee KL, Redfield MM, Tracy RP, Braunwald E, O'Connor CM, Felker GM. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure Circulation: Heart Failure. 6: 240-245. PMID 23250981 DOI: 10.1161/Circheartfailure.112.969246  0.358
2013 Lopes RD, White JA, Tricoci P, White HD, Armstrong PW, Braunwald E, Giugliano RP, Harrington RA, Lewis BS, Brogan GX, Gibson CM, Califf RM, Newby LK. Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trial. International Journal of Cardiology. 167: 2580-7. PMID 22795720 DOI: 10.1016/J.Ijcard.2012.06.053  0.35
2013 O'Malley RG, Sabatine M, Bonaca M, Murphy S, Jarolim P, Conrad M, Cannon C, Braunwald E, Morrow D. PROGNOSTIC PERFORMANCE OF SERIAL HIGH SENSITIVITY CARDIAC TROPONIN DETERMINATION IN STABLE ISCHEMIC HEART DISEASE: ANALYSIS FROM PROVE IT-TIMI 22 Journal of the American College of Cardiology. 61: E1147. DOI: 10.1016/S0735-1097(13)61147-X  0.374
2013 Gupta DK, Shah A, Giugliano R, Ruff C, Antman E, Grip LT, Deenadayalu N, Hoffman E, Betcher J, Patel I, Shi M, Braunwald E, Solomon S. CARDIAC STRUCTURE AND FUNCTION AND CHADS2 RISK SCORE IN PATIENTS WITH ATRIAL FIBRILLATION: THE EFFECTS ANTICOAGULATION WITH FACTOR XA NEXT GENERATION IN AFTHROMBOLYSIS IN MYOCARDIAL INFARCTION 48 (ENGAGE AF -TIMI 48) ECHOCARDIOGRAPHIC STUDY Journal of the American College of Cardiology. 61: E964. DOI: 10.1016/S0735-1097(13)60964-X  0.397
2013 Grinstein J, Bonaca M, Sabatine M, Jarolim P, Conrad M, Braunwald E, Giugliano R, Newby LK, Morrow D. PROGNOSTIC IMPLICATIONS OF LOW-LEVEL CARDIAC TROPONIN ELEVATION USING THE HIGH-SENSITIVITY ASSAY FOR CARDIAC TROPONIN T: RESULTS FROM EARLY ACS & SEPIA-TIMI 42 Journal of the American College of Cardiology. 61: E110. DOI: 10.1016/S0735-1097(13)60111-4  0.306
2013 Cavender M, Braunwald E, Gibson CM, Wiviott S, Murphy S, Amuchastegui M, Ophuis AO, van Hessen M, Mega J. RIVAROXABAN REDUCES SPONTANEOUS AND LARGE MYOCARDIAL INFARCTIONS: FINDINGS FROM THE ATLAS ACS 2 – TIMI 51 TRIAL Journal of the American College of Cardiology. 61: E3. DOI: 10.1016/S0735-1097(13)60004-2  0.372
2012 Braunwald E. Hypertrophic cardiomyopathy: The first century 1869-1969. Global Cardiology Science & Practice. 2012: 5. PMID 25610836 DOI: 10.5339/Gcsp.2012.5  0.344
2012 Shah RV, McNulty S, O'Connor CM, Felker GM, Braunwald E, Givertz MM. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure. American Heart Journal. 164: 862-8. PMID 23194486 DOI: 10.1016/J.Ahj.2012.08.019  0.344
2012 Bishu K, Deswal A, Chen HH, Lewinter MM, Lewis GD, Semigran MJ, Borlaug BA, McNulty S, Hernandez AF, Braunwald E, Redfield MM. Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction American Heart Journal. 164: 763-e3. PMID 23137508 DOI: 10.1016/J.Ahj.2012.08.014  0.33
2012 Bart BA, Goldsmith SR, Lee KL, Givertz MM, O'Connor CM, Bull DA, Redfield MM, Deswal A, Rouleau JL, LeWinter MM, Ofili EO, Stevenson LW, Semigran MJ, Felker GM, Chen HH, ... ... Braunwald E, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. The New England Journal of Medicine. 367: 2296-304. PMID 23131078 DOI: 10.1056/Nejmoa1210357  0.353
2012 Mogabgab O, Giugliano RP, Sabatine MS, Cannon CP, Mohanavelu S, Wiviott SD, Antman EM, Braunwald E. Circadian variation in patient characteristics and outcomes in ST-segment elevation myocardial infarction. Chronobiology International. 29: 1390-6. PMID 23131034 DOI: 10.3109/07420528.2012.728658  0.365
2012 Braunwald E. Chronic heart failure: a look through the rear view mirror. European Heart Journal. 34: 1391-2. PMID 23103661 DOI: 10.1093/Eurheartj/Ehs363  0.364
2012 Braunwald E. Obstruction in hypertrophic cardiomyopathy: how often does it occur? Should it be treated? If so, how? Circulation. 126: 2369-70. PMID 23076969 DOI: 10.1161/Circulationaha.112.144667  0.418
2012 Pride YB, Mohanavelu S, Zorkun C, Kunadian V, Giugliano RP, Newby LK, Braunwald E, Califf RM, Harrington RA, Gibson CM. Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy. Jacc. Cardiovascular Interventions. 5: 927-35. PMID 22995880 DOI: 10.1016/J.Jcin.2012.05.007  0.364
2012 Redfield MM, Borlaug BA, Lewis GD, Mohammed SF, Semigran MJ, Lewinter MM, Deswal A, Hernandez AF, Lee KL, Braunwald E. PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design. Circulation. Heart Failure. 5: 653-9. PMID 22991405 DOI: 10.1161/Circheartfailure.112.969071  0.384
2012 Scirica BM, Bonaca MP, Braunwald E, De Ferrari GM, Isaza D, Lewis BS, Mehrhof F, Merlini PA, Murphy SA, Sabatine MS, Tendera M, Van de Werf F, Wilcox R, Morrow DA. Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial. Lancet (London, England). 380: 1317-24. PMID 22932716 DOI: 10.1016/S0140-6736(12)61269-0  0.35
2012 Braunwald E, Sabatine MS. The Thrombolysis in Myocardial Infarction (TIMI) Study Group experience. The Journal of Thoracic and Cardiovascular Surgery. 144: 762-70. PMID 22901500 DOI: 10.1016/J.Jtcvs.2012.07.001  0.352
2012 Bonaca MP, Scirica BM, Sabatine MS, Jarolim P, Murphy SA, Chamberlin JS, Rhodes DW, Southwick PC, Braunwald E, Morrow DA. Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes. Journal of the American College of Cardiology. 60: 332-8. PMID 22813612 DOI: 10.1016/J.Jacc.2012.04.023  0.323
2012 O'Donoghue ML, Vaidya A, Afsal R, Alfredsson J, Boden WE, Braunwald E, Cannon CP, Clayton TC, de Winter RJ, Fox KA, Lagerqvist B, McCullough PA, Murphy SA, Spacek R, Swahn E, et al. An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trials. Journal of the American College of Cardiology. 60: 106-11. PMID 22766336 DOI: 10.1016/J.Jacc.2012.02.059  0.331
2012 Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, et al. Vorapaxar in the secondary prevention of atherothrombotic events. The New England Journal of Medicine. 366: 1404-13. PMID 22443427 DOI: 10.1056/Nejmoa1200933  0.366
2012 Braunwald E. The rise of cardiovascular medicine. European Heart Journal. 33: 838-45, 845a. PMID 22416074 DOI: 10.1093/Eurheartj/Ehr452  0.429
2012 Bart BA, Goldsmith SR, Lee KL, Redfield MM, Felker GM, O'Connor CM, Chen HH, Rouleau JL, Givertz MM, Semigran MJ, Mann D, Deswal A, Bull DA, Lewinter MM, Braunwald E. Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network. Journal of Cardiac Failure. 18: 176-82. PMID 22385937 DOI: 10.1016/J.Cardfail.2011.12.009  0.315
2012 Røysland R, Bonaca MP, Omland T, Sabatine M, Murphy SA, Scirica BM, Bjerre M, Flyvbjerg A, Braunwald E, Morrow DA. Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes. Heart (British Cardiac Society). 98: 786-91. PMID 22373720 DOI: 10.1136/Heartjnl-2011-301260  0.352
2012 Nabel EG, Braunwald E. A tale of coronary artery disease and myocardial infarction. The New England Journal of Medicine. 366: 54-63. PMID 22216842 DOI: 10.1056/Nejmra1112570  0.405
2012 Bonaca MP, Wiviott SD, Braunwald E, Murphy SA, Ruff CT, Antman EM, Morrow DA. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation Universal definition of myocardial infarction classification system and the risk of cardiovascular death: Observations from the TRITON-TIMI 38 trial Circulation. 125: 577-583. PMID 22199016 DOI: 10.1161/Circulationaha.111.041160  0.407
2012 Sabatine MS, Morrow DA, de Lemos JA, Omland T, Sloan S, Jarolim P, Solomon SD, Pfeffer MA, Braunwald E. Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease. Circulation. 125: 233-40. PMID 22179538 DOI: 10.1161/Circulationaha.111.063842  0.381
2012 Grandin EW, Jarolim P, Murphy SA, Ritterova L, Cannon CP, Braunwald E, Morrow DA. Galectin-3 and the development of heart failure after acute coronary syndrome: Pilot experience from PROVE IT-TIMI 22 Clinical Chemistry. 58: 267-273. PMID 22110019 DOI: 10.1373/Clinchem.2011.174359  0.386
2012 Kohli P, Bonaca MP, Kakkar R, Kudinova AY, Scirica BM, Sabatine MS, Murphy SA, Braunwald E, Lee RT, Morrow DA. Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial. Clinical Chemistry. 58: 257-66. PMID 22096031 DOI: 10.1373/Clinchem.2011.173369  0.416
2012 Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, et al. Rivaroxaban in patients with a recent acute coronary syndrome. The New England Journal of Medicine. 366: 9-19. PMID 22077192 DOI: 10.1056/Nejmoa1112277  0.345
2012 Ruff CT, Giugliano RP, Antman EM, Murphy SA, Lotan C, Heuer H, Merkely B, Baracioli L, Schersten F, Seabro-Gomes R, Braunwald E, Wiviott SD. Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world International Journal of Cardiology. 155: 424-429. PMID 21093072 DOI: 10.1016/J.Ijcard.2010.10.040  0.334
2012 Udell JA, O'Donnell T, Morrow D, Jarolim P, Omland T, Sloan S, Pfeffer M, Braunwald E, Sabatine M. ASSOCIATION OF FIBROBLAST GROWTH FACTOR (FGF)-23 LEVELS WITH RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE Journal of the American College of Cardiology. 59: E1480. DOI: 10.1016/S0735-1097(12)61481-8  0.323
2012 O'Malley RG, Bonaca M, Sabatine M, Scirica B, Jarolim P, Conrad M, Murphy S, Braunwald E, Morrow D. PROGNOSTIC PERFORMANCE OF A SINGLE-MOLECULE HIGH-SENSITIVITY CARDIAC TROPONIN ASSAY AFTER NON-ST ELEVATION ACUTE CORONARY SYNDROME: ANALYSIS FROM MERLIN-TIMI 36 Journal of the American College of Cardiology. 59: E402. DOI: 10.1016/S0735-1097(12)60403-3  0.346
2012 Kohli P, Morrow D, Murphy S, Cannon C, Ridker P, Braunwald E, Sabatine M. PROGNOSTIC VALUE OF SERIAL C-REACTIVE PROTEIN LEVELS AFTER AN ACUTE CORONARY SYNDROME: AN ANALYSIS FROM PROVE-IT TIMI 22 Journal of the American College of Cardiology. 59: E399. DOI: 10.1016/S0735-1097(12)60400-8  0.308
2012 Scirica B, Morrow D, Antman E, Bonaca M, Murphy S, Braunwald E, Wiviott S. TIMING AND CLINICAL SETTING OF CARDIOVASCULAR DEATH OR MYOCARDIAL INFARCTION FOLLOWING PCI FOR ACS – OBSERVATIONS FROM THE TRITON-TIMI 38 TRIAL Journal of the American College of Cardiology. 59: E340. DOI: 10.1016/S0735-1097(12)60341-6  0.379
2011 Braunwald E. Unstable angina and non-ST elevation myocardial infarction. American Journal of Respiratory and Critical Care Medicine. 185: 924-32. PMID 22205565 DOI: 10.1164/Rccm.201109-1745Ci  0.409
2011 Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Price DL, Chen R, Udell J, Raz I. The design and rationale of the saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI) 53 study. American Heart Journal. 162: 818-825.e6. PMID 22093196 DOI: 10.1016/J.Ahj.2011.08.006  0.343
2011 Gheorghiade M, Braunwald E. Hospitalizations for heart failure in the United States--a sign of hope. Jama. 306: 1705-1706. PMID 22009103 DOI: 10.1001/Jama.2011.1510  0.32
2011 O'Donoghue ML, Braunwald E, White HD, Serruys P, Steg PG, Hochman J, Maggioni AP, Bode C, Weaver D, Johnson JL, Cicconetti G, Lukas MA, Tarka E, Cannon CP. Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome. American Heart Journal. 162: 613-619.e1. PMID 21982651 DOI: 10.1016/J.Ahj.2011.07.018  0.383
2011 Schwartz Longacre L, Kloner RA, Arai AE, Baines CP, Bolli R, Braunwald E, Downey J, Gibbons RJ, Gottlieb RA, Heusch G, Jennings RB, Lefer DJ, Mentzer RM, Murphy E, Ovize M, et al. New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation. 124: 1172-9. PMID 21900096 DOI: 10.1161/Circulationaha.111.032698  0.442
2011 Harkness JR, Morrow DA, Braunwald E, Ren F, Lopez-Sendon J, Bode C, Budaj A, Scirica BM. Myocardial ischemia and ventricular tachycardia on continuous electrocardiographic monitoring and risk of cardiovascular outcomes after non-ST-segment elevation acute coronary syndrome (from the MERLIN-TIMI 36 Trial). The American Journal of Cardiology. 108: 1373-81. PMID 21890090 DOI: 10.1016/J.Amjcard.2011.06.058  0.443
2011 Braunwald E. Clinical efforts to reduce myocardial infarct size--the next step. Journal of Cardiovascular Pharmacology and Therapeutics. 16: 349-353. PMID 21821538 DOI: 10.1177/1074248411407637  0.419
2011 Wiviott SD, Desai N, Murphy SA, Musumeci G, Ragosta M, Antman EM, Braunwald E. Efficacy and safety of intensive antiplatelet therapy with prasugrel from TRITON-TIMI 38 in a core clinical cohort defined by worldwide regulatory agencies. The American Journal of Cardiology. 108: 905-11. PMID 21816379 DOI: 10.1016/J.Amjcard.2011.05.020  0.377
2011 O'Donoghue ML, Mallat Z, Morrow DA, Benessiano J, Sloan S, Omland T, Solomon SD, Braunwald E, Tedgui A, Sabatine MS. Prognostic utility of secretory phospholipase A(2) in patients with stable coronary artery disease. Clinical Chemistry. 57: 1311-7. PMID 21784767 DOI: 10.1373/Clinchem.2011.166520  0.334
2011 Tricoci P, Newby LK, Hasselblad V, Kong DF, Giugliano RP, White HD, Théroux P, Stone GW, Moliterno DJ, Werf FVd, Armstrong PW, Prabhakaran D, Rasoul S, Bolognese L, Durand E, ... Braunwald E, et al. Upstream Use of Small-Molecule Glycoprotein IIb/IIIa Inhibitors in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes A Systematic Overview of Randomized Clinical Trials Circulation-Cardiovascular Quality and Outcomes. 4: 448-458. PMID 21712522 DOI: 10.1161/Circoutcomes.110.960294  0.321
2011 Hochholzer W, Wiviott SD, Antman EM, Contant CF, Guo J, Giugliano RP, Dalby AJ, Montalescot G, Braunwald E. Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38). Circulation. 123: 2681-9. PMID 21606391 DOI: 10.1161/Circulationaha.110.002683  0.374
2011 Gibson CM, Mega JL, Burton P, Goto S, Verheugt F, Bode C, Plotnikov A, Sun X, Cook-Bruns N, Braunwald E. Rationale and design of the Anti-Xa therapy to lower cardiovascular events in addition to standard therapy in subjects with acute coronary syndrome-thrombolysis in myocardial infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome. American Heart Journal. 161: 815-821.e6. PMID 21570509 DOI: 10.1016/J.Ahj.2011.01.026  0.393
2011 Gheorghiade M, Braunwald E. A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes Jama. 305: 1702-1703. PMID 21521852 DOI: 10.1001/Jama.2011.515  0.31
2011 Braunwald E, Sacks FM, Pfeffer MA, Ridker PM. HMG CoA reduction in patients with average cholesterol concentrations. Clinical Chemistry. 57: 1072-3. PMID 21519035 DOI: 10.1373/Clinchem.2011.164038  0.352
2011 Vardeny O, Uno H, Braunwald E, Rouleau JL, Gersh B, Maggioni AP, Domanski M, Pfeffer MA, Solomon SD. Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease. The American Journal of Cardiology. 107: 1705-9. PMID 21507365 DOI: 10.1016/J.Amjcard.2011.01.064  0.302
2011 Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, ... ... Braunwald E, et al. Diuretic strategies in patients with acute decompensated heart failure. The New England Journal of Medicine. 364: 797-805. PMID 21366472 DOI: 10.1056/Nejmoa1005419  0.381
2011 Nazer B, Ray KK, Sloan S, Scirica B, Morrow DA, Cannon CP, Braunwald E. Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome European Heart Journal. 32: 1390-1397. PMID 21345849 DOI: 10.1093/Eurheartj/Ehr032  0.344
2011 Wang TY, White JA, Tricoci P, Giugliano RP, Zeymer U, Harrington RA, Montalescot G, James SK, Van de Werf F, Armstrong PW, Braunwald E, Califf RM, Newby LK. Upstream clopidogrel use and the efficacy and safety of early eptifibatide treatment in patients with acute coronary syndrome: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial. Circulation. 123: 722-30. PMID 21300952 DOI: 10.1161/Circulationaha.110.958041  0.374
2011 Scirica BM, Sabatine MS, Jarolim P, Murphy SA, de Lemos JL, Braunwald E, Morrow DA. Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial. European Heart Journal. 32: 697-705. PMID 21183500 DOI: 10.1093/Eurheartj/Ehq468  0.427
2011 Ruff CT, Braunwald E. The evolving epidemiology of acute coronary syndromes Nature Reviews Cardiology. 8: 140-147. PMID 21173793 DOI: 10.1038/Nrcardio.2010.199  0.378
2011 Giugliano RP, Braunwald E. The year in non-ST-segment elevation acute coronary syndrome. Journal of the American College of Cardiology. 56: 2126-38. PMID 21144974 DOI: 10.1016/J.Jacc.2010.09.016  0.359
2011 Scirica BM, Braunwald E, Hedgepeth CM, Qin J, Morrow DA, Belardinelli L, Wang W, Karwatowska-Prokopczuk E, Spinar J, Verheugt FWA. Response to Letters Regarding Article, “Relationship Between Nonsustained Ventricular Tachycardia After Non-ST-Elevation Acute Coronary Syndrome and Sudden Cardiac Death: Observations From the Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) Randomized Controlled Trial” Circulation. 123. DOI: 10.1161/Circulationaha.110.003525  0.429
2011 O'Malley RG, Bonaca MP, Sabatine MS, Scirica BM, Murphy SA, Jarolim P, Braunwald E, Morrow DA. C-TERMINAL PROVASOPRESSIN (COPEPTIN), MID-REGION PRO-ADRENOMEDULLIN (MR-PROADM) AND MID-REGION PRO-ATRIAL NATRIURETIC PEPTIDE (MR-PROANP) AS NOVEL PROGNOSTIC BIOMARKERS AFTER NON-ST ELEVATION ACUTE CORONARY SYNDROME: ANALYSIS FROM MERLIN TIMI-36 Journal of the American College of Cardiology. 57: E1020. DOI: 10.1016/S0735-1097(11)61020-6  0.32
2011 Bonaca MP, Braunwald E, Murphy SA, Miller D, Herrman JR, Gottlieb S, Menozzi A, McCabe CH, Antman EM, Wiviott SW. LONG-TERM THIENOPYRIDINE THERAPY AND OUTCOMES IN PATIENTS WITH ACS TREATED WITH CORONARY STENTING: THE PRIMARY RESULTS OF THE TIMI-38 CORONARY STENT REGISTRY Journal of the American College of Cardiology. 57: E906. DOI: 10.1016/S0735-1097(11)60906-6  0.328
2011 Kociol RD, McNulty SE, Hernandez AF, Lee KL, Redfield MM, Tracy RP, Braunwald E, O'Connor CM, Felker GM. MARKERS OF CONGESTION, SYMPTOM RELIEF AND CLINICAL OUTCOMES AMONG PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE: DATA FROM THE DIURETIC OPTIMAL STRATEGY EVALUATION IN ACUTE HEART FAILURE STUDY Journal of the American College of Cardiology. 57: E220. DOI: 10.1016/S0735-1097(11)60220-9  0.361
2011 Ohtani T, Felker GM, McNulty SE, LeWinter MM, Braunwald E, Redfield MM. Plasma Renin Activity (PRA) Predicts Diuretic Resistance in Acute Heart Failure Patients: An Ancillary Study of the Diuretic Optimization Strategies Evaluation in Acute Heart Failure (DOSE-AHF) Journal of Cardiac Failure. 17: S25-S26. DOI: 10.1016/J.Cardfail.2011.06.087  0.344
2010 Bonaca MP, Morrow DA, Braunwald E, Cannon CP, Jiang S, Breher S, Sabatine MS, Kempf T, Wallentin L, Wollert KC. Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22. Arteriosclerosis, Thrombosis, and Vascular Biology. 31: 203-10. PMID 20966402 DOI: 10.1161/Atvbaha.110.213512  0.381
2010 Rich JD, Cannon CP, Murphy SA, Qin J, Giugliano RP, Braunwald E. Prior aspirin use and outcomes in acute coronary syndromes Journal of the American College of Cardiology. 56: 1376-1385. PMID 20946994 DOI: 10.1016/J.Jacc.2010.06.028  0.398
2010 Ruff CT, Giugliano RP, Antman EM, Crugnale SE, Bocanegra T, Mercuri M, Hanyok J, Patel I, Shi M, Salazar D, McCabe CH, Braunwald E. Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48). American Heart Journal. 160: 635-41. PMID 20934556 DOI: 10.1016/J.Ahj.2010.06.042  0.31
2010 Shah AM, Pfeffer MA, Hartley LH, Moyé LA, Gersh BJ, Rutherford JD, Lamas GA, Rouleau JL, Braunwald E, Solomon SD. Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction. The American Journal of Cardiology. 106: 911-6. PMID 20854949 DOI: 10.1016/J.Amjcard.2010.05.021  0.344
2010 Mega JL, Close SL, Wiviott SD, Shen L, Walker JR, Simon T, Antman EM, Braunwald E, Sabatine MS. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis. Lancet (London, England). 376: 1312-9. PMID 20801494 DOI: 10.1016/S0140-6736(10)61273-1  0.353
2010 Pride YB, Tung P, Mohanavelu S, Zorkun C, Wiviott SD, Antman EM, Giugliano R, Braunwald E, Gibson CM. Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) substudy. Jacc. Cardiovascular Interventions. 3: 806-11. PMID 20723851 DOI: 10.1016/J.Jcin.2010.05.012  0.375
2010 Peacock WF, Braunwald E, Abraham W, Albert N, Burnett J, Christenson R, Collins S, Diercks D, Fonarow G, Hollander J, Kellerman A, Gheorghiade M, Kirk D, Levy P, Maisel A, et al. National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities. Journal of the American College of Cardiology. 56: 343-51. PMID 20650354 DOI: 10.1016/J.Jacc.2010.03.051  0.342
2010 Scirica BM, Braunwald E, Belardinelli L, Hedgepeth CM, Spinar J, Wang W, Qin J, Karwatowska-Prokopczuk E, Verheugt FWA, Morrow DA. Relationship Between Nonsustained Ventricular Tachycardia After Non–ST-Elevation Acute Coronary Syndrome and Sudden Cardiac Death Observations From the Metabolic Efficiency With Ranolazine for Less Ischemia in Non–ST-Elevation Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) Randomized Controlled Trial Circulation. 122: 455-462. PMID 20644019 DOI: 10.1161/Circulationaha.110.937136  0.442
2010 Sherwood MW, Morrow DA, Scirica BM, Jiang S, Bode C, Rifai N, Gerszten RE, Gibson CM, Cannon CP, Braunwald E, Sabatine MS. Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28. American Heart Journal. 159: 964-971.e1. PMID 20569707 DOI: 10.1016/J.Ahj.2010.03.005  0.379
2010 Scirica BM, Morrow DA, Bode C, Ruzyllo W, Ruda M, Oude Ophuis AJ, Lopez-Sendon J, Swedberg K, Ogorek M, Rifai N, Lukashevich V, Maboudian M, Cannon CP, McCabe CH, Braunwald E. Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial. European Heart Journal. 31: 1993-2005. PMID 20558431 DOI: 10.1093/Eurheartj/Ehq190  0.364
2010 Ruff CT, Braunwald E. Will warfarin ever be replaced? Journal of Cardiovascular Pharmacology and Therapeutics. 15: 210-219. PMID 20484119 DOI: 10.1177/1074248410366448  0.353
2010 Bonaca M, Scirica B, Sabatine M, Dalby A, Spinar J, Murphy SA, Jarolim P, Braunwald E, Morrow DA. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. Journal of the American College of Cardiology. 55: 2118-24. PMID 20447535 DOI: 10.1016/J.Jacc.2010.01.044  0.377
2010 Giugliano RP, Giraldez RR, Morrow DA, Antman EM, Gibson CM, Mohanavelu S, Murphy SA, McCabe CH, Braunwald E. Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial. European Heart Journal. 31: 2103-10. PMID 20413397 DOI: 10.1093/Eurheartj/Ehq100  0.395
2010 Morrow DA, Antman EM, Fox KAA, White HD, Giugliano R, Murphy SA, McCabe CH, Braunwald E. One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 Trial European Heart Journal. 31: 2097-2102. PMID 20400762 DOI: 10.1093/Eurheartj/Ehq098  0.341
2010 Chisholm JW, Goldfine AB, Dhalla AK, Braunwald E, Morrow DA, Karwatowska-Prokopczuk E, Belardinelli L. Effect of ranolazine on A1C and glucose levels in hyperglycemic patients with non-ST elevation acute coronary syndrome Diabetes Care. 33: 1163-1168. PMID 20357382 DOI: 10.2337/Dc09-2334  0.306
2010 Morrow DA, Scirica BM, Sabatine MS, de Lemos JA, Murphy SA, Jarolim P, Theroux P, Bode C, Braunwald E. B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary-Thrombolysis In Myocardial Infarction 36) trial. Journal of the American College of Cardiology. 55: 1189-96. PMID 20298924 DOI: 10.1016/J.Jacc.2009.09.068  0.426
2010 Harkness JR, Sabatine MS, Braunwald E, Morrow DA, Sloan S, Wiviott SD, Giugliano RP, Antman EM, Cannon CP, Scirica BM. Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction. American Heart Journal. 159: 55-62. PMID 20102867 DOI: 10.1016/J.Ahj.2009.10.033  0.312
2010 Mahoney EM, Wang K, Arnold SV, Proskorovsky I, Wiviott S, Antman E, Braunwald E, Cohen DJ. Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38. Circulation. 121: 71-9. PMID 20026770 DOI: 10.1161/Circulationaha.109.900704  0.38
2010 Epstein SE, Beiser GD, Stampfer M, Braunwald E. Role of the venous system in baroreceptor-mediated reflexes in man. The Journal of Clinical Investigation. 47: 139-52. PMID 16695936 DOI: 10.1172/Jci105704  0.314
2010 Mahoney EM, Wang K, Arnold SV, Cohen DJ, Proskorovsky I, Wiviott S, Antman E, Braunwald E. Response to Letter Regarding Article, “Cost-Effectiveness of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndromes and Planned Percutaneous Coronary Intervention: Results From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38” Circulation. 122. DOI: 10.1161/Circulationaha.110.951889  0.339
2010 Wang T, White JA, Giugliano RP, Tricoci P, Harrington RA, Montalescot G, Zeymer U, Van de Werf F, Armstrong PW, Braunwald E, Califf RM, Newby LK. UPFRONT CLOPIDOGREL USE AND THE EFFICACY AND SAFETY OF EARLY EPTIFIBATIDE USE IN PATIENTS WITH ACUTE CORONARY SYNDROME: AN ANALYSIS FROM THE EARLY VERSUS DELAYED PROVISIONAL EPTIFIBATIDE IN ACUTE CORONARY SYNDROMES (EARLY ACS) TRIAL Journal of the American College of Cardiology. 55: A47.E451. DOI: 10.1016/S0735-1097(10)60452-4  0.333
2009 Braunwald E. Hypertrophic cardiomyopathy: the early years. Journal of Cardiovascular Translational Research. 2: 341-8. PMID 20559993 DOI: 10.1007/S12265-009-9128-3  0.322
2009 Murphy SA, Cannon CP, Wiviott SD, McCabe CH, Braunwald E. Reduction in Recurrent Cardiovascular Events With Intensive Lipid-Lowering Statin Therapy Compared With Moderate Lipid-Lowering Statin Therapy After Acute Coronary Syndromes: From the PROVE IT–TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22) Trial Journal of the American College of Cardiology. 54: 2358-2362. PMID 20082923 DOI: 10.1016/J.Jacc.2009.10.005  0.343
2009 Arnold SV, Morrow DA, Lei Y, Cohen DJ, Mahoney EM, Braunwald E, Chan PS. Economic impact of angina after an acute coronary syndrome insights from the merlin-timi 36 trial Circulation: Cardiovascular Quality and Outcomes. 2: 344-353. PMID 20031860 DOI: 10.1161/Circoutcomes.108.829523  0.346
2009 Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, Tjora S, Domanski MJ, Gersh BJ, Rouleau JL, Pfeffer MA, Braunwald E. A sensitive cardiac troponin T assay in stable coronary artery disease. The New England Journal of Medicine. 361: 2538-47. PMID 19940289 DOI: 10.1056/Nejmoa0805299  0.362
2009 Gheorghiade M, Braunwald E. Reconsidering the Role for Digoxin in the Management of Acute Heart Failure Syndromes Jama. 302: 2146-2147. PMID 19920240 DOI: 10.1001/Jama.2009.1657  0.41
2009 Giugliano RP, Braunwald E. The year in non-ST-segment elevation acute coronary syndrome. Journal of the American College of Cardiology. 54: 1544-55. PMID 19815127 DOI: 10.1016/J.Jacc.2009.06.025  0.339
2009 Lewis EF, Solomon SD, Jablonski KA, Rice MM, Clemenza F, Hsia J, Maggioni AP, Zabalgoitia M, Huynh T, Cuddy TE, Gersh BJ, Rouleau J, Braunwald E, Pfeffer MA. Predictors of heart failure in patients with stable coronary artery disease: a PEACE study. Circulation. Heart Failure. 2: 209-16. PMID 19808342 DOI: 10.1161/Circheartfailure.108.820696  0.418
2009 Braunwald E. The management of heart failure: the past, the present, and the future. Circulation. Heart Failure. 1: 58-62. PMID 19808271 DOI: 10.1161/Circheartfailure.107.752162  0.319
2009 Felker GM, O'Connor CM, Braunwald E. Loop diuretics in acute decompensated heart failure necessary? Evil? A necessary evil? Circulation: Heart Failure. 2: 56-62. PMID 19750134 DOI: 10.1161/Circheartfailure.108.821785  0.345
2009 Sabatine MS, Antman EM, Widimsky P, Ebrahim IO, Kiss RG, Saaiman A, Polasek R, Contant CF, McCabe CH, Braunwald E. Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial The Lancet. 374: 787-795. PMID 19717184 DOI: 10.1016/S0140-6736(09)61454-9  0.332
2009 Wilson SR, Sabatine MS, Braunwald E, Sloan S, Murphy SA, Morrow DA. Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial. American Heart Journal. 158: 386-91. PMID 19699861 DOI: 10.1016/J.Ahj.2009.06.011  0.383
2009 Pride YB, Wiviott SD, Buros JL, Zorkun C, Tariq MU, Antman EM, Braunwald E, Gibson CM. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy. American Heart Journal. 158: e21-6. PMID 19699846 DOI: 10.1016/J.Ahj.2009.06.021  0.364
2009 O'Donoghue M, Antman EM, Braunwald E, Murphy SA, Steg PG, Finkelstein A, Penny WF, Fridrich V, McCabe CH, Sabatine MS, Wiviott SD. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis. Journal of the American College of Cardiology. 54: 678-85. PMID 19679245 DOI: 10.1016/J.Jacc.2009.05.025  0.332
2009 Braunwald E. Acute coronary syndromes: BNP measurement predicts AMI risk in the elderly. Nature Reviews. Cardiology. 6: 503-4. PMID 19633678 DOI: 10.1038/Nrcardio.2009.118  0.329
2009 Braunwald E. Biomarkers in heart failure. Preface. Heart Failure Clinics. 5: xiii-xiv. PMID 19631171 DOI: 10.1016/J.Hfc.2009.05.002  0.328
2009 Braunwald E. Adventures in cardiovascular research. Circulation. 120: 170-80. PMID 19597062 DOI: 10.1161/Circulationaha.109.860965  0.369
2009 Maron BJ, Maron MS, Wigle ED, Braunwald E. The 50-Year History, Controversy, and Clinical Implications of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy: From Idiopathic Hypertrophic Subaortic Stenosis to Hypertrophic Cardiomyopathy Journal of the American College of Cardiology. 54: 191-200. PMID 19589431 DOI: 10.1016/J.Jacc.2008.11.069  0.364
2009 Braunwald E. Noninvasive detection of vulnerable coronary plaques: Locking the barn door before the horse is stolen. Journal of the American College of Cardiology. 54: 58-59. PMID 19555841 DOI: 10.1016/J.Jacc.2009.03.040  0.335
2009 Mega J, Braunwald E, Mohanavelu S, Burton P, Poulter R, Misselwitz F, Hricak V, Barnathan E, Bordes P, Witkowski A, Markov V, Oppenheimer L, Gibson C. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial The Lancet. 374: 29-38. PMID 19539361 DOI: 10.1016/S0140-6736(09)60738-8  0.341
2009 Morrow DA, Wiviott SD, White HD, Nicolau JC, Bramucci E, Murphy SA, Bonaca MP, Ruff CT, Scirica BM, McCabe CH, Antman EM, Braunwald E. Effect of the Novel Thienopyridine Prasugrel Compared With Clopidogrel on Spontaneous and Procedural Myocardial Infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38 An Application of the Classification System From the Universal Definition of Myocardial Infarction Circulation. 119: 2758-2764. PMID 19451347 DOI: 10.1161/Circulationaha.108.833665  0.414
2009 Charytan DM, Wallentin L, Lagerqvist B, Spacek R, De Winter RJ, Stern NM, Braunwald E, Cannon CP, Choudhry NK. Early angiography in patients with chronic kidney disease: a collaborative systematic review. Clinical Journal of the American Society of Nephrology : Cjasn. 4: 1032-43. PMID 19423566 DOI: 10.2215/Cjn.05551008  0.354
2009 Braunwald E. JACC: Cardiovascular Interventions: the end of the beginning. Jacc. Cardiovascular Interventions. 1: 1-2. PMID 19393136 DOI: 10.1016/J.Jcin.2007.12.003  0.317
2009 Wilson SR, Scirica BM, Braunwald E, Murphy SA, Karwatowska-Prokopczuk E, Buros JL, Chaitman BR, Morrow DA. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial. Journal of the American College of Cardiology. 53: 1510-6. PMID 19389561 DOI: 10.1016/J.Jacc.2009.01.037  0.35
2009 Scirica BM, Morrow DA, Budaj A, Dalby AJ, Mohanavelu S, Qin J, Aroesty J, Hedgepeth CM, Stone PH, Braunwald E. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial. Journal of the American College of Cardiology. 53: 1411-21. PMID 19371824 DOI: 10.1016/J.Jacc.2008.12.053  0.378
2009 Morrow DA, Scirica BM, Chaitman BR, McGuire DK, Murphy SA, Prokopczuk EK, McCabe CH, Braunwald E. Evaluation of the Glycometabolic Effects of Ranolazine in Patients With and Without Diabetes Mellitus in the MERLIN-TIMI 36 Randomized Controlled Trial Circulation. 119: 2032-2039. PMID 19349325 DOI: 10.1161/Circulationaha.107.763912  0.334
2009 Giugliano RP, White JA, Bode C, Armstrong PW, Montalescot G, Lewis BS, van 't Hof A, Berdan LG, Lee KL, Strony JT, Hildemann S, Veltri E, Van de Werf F, Braunwald E, Harrington RA, et al. Early versus delayed, provisional eptifibatide in acute coronary syndromes. The New England Journal of Medicine. 360: 2176-90. PMID 19332455 DOI: 10.1056/Nejmoa0901316  0.341
2009 Truong QA, Cannon CP, Zakai NA, Rogers IS, Giugliano RP, Wiviott SD, McCabe CH, Morrow DA, Braunwald E. Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial. American Heart Journal. 157: 673-9.e1. PMID 19332194 DOI: 10.1016/J.Ahj.2008.12.010  0.414
2009 Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, McCabe CH, Antman EM. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial The Lancet. 373: 723-731. PMID 19249633 DOI: 10.1016/S0140-6736(09)60441-4  0.384
2009 Giraldez RR, Sabatine MS, Morrow DA, Mohanavelu S, McCabe CH, Antman EM, Braunwald E. Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction American Heart Journal. 157: 517-524. PMID 19249423 DOI: 10.1016/J.Ahj.2008.10.021  0.384
2009 Ray KK, Cannon CP, Cairns R, Morrow DA, Ridker PM, Braunwald E. Prognostic utility of ApoB/AI, total cholesterol/HDL, Non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes results from PROVE IT-TIMI 22 Arteriosclerosis, Thrombosis, and Vascular Biology. 29: 423-430. PMID 19122170 DOI: 10.1161/Atvbaha.108.181735  0.312
2009 Daemen J, Simoons ML, Wijns W, Bagust A, Bos G, Bowen JM, Braunwald E, Camenzind E, Chevalier B, Dimario C, Fajadet J, Gitt A, Guagliumi G, Hillege HL, James S, ... ... Braunwald E, et al. ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007. European Heart Journal. 30: 152-61. PMID 19036745 DOI: 10.1093/Eurheartj/Ehn510  0.323
2009 Sabatine MS, Morrow DA, de Lemos JA, Jarolim P, Braunwald E. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. European Heart Journal. 30: 162-9. PMID 18997177 DOI: 10.1093/Eurheartj/Ehn504  0.33
2009 Cannon CP, Bahit MC, Haugland JM, Henry TD, Schweiger MJ, McKendall GR, Shah PK, Murphy S, Gibson CM, McCabe CH, Antman EM, Braunwald E. Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry. Critical Pathways in Cardiology. 1: 44-52. PMID 18340288 DOI: 10.1097/00132577-200203000-00007  0.42
2009 Cannon CP, Braunwald E. Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) acute coronary syndromes Critical Pathway Toolkit. Critical Pathways in Cardiology. 2: 153-77. PMID 18340119 DOI: 10.1097/01.Hpc.0000085366.42909.60  0.343
2009 Wiviott SD, Braunwald E, Murphy SA, McCabe CH, Antman EM, Angiolillo DJ, Meisel S, Dalby AJ, Verheugt FWA, Goodman SG, Corbalan R, Purdy DA. Response to letter regarding article, "greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel: Thrombolysis in myocardial infarction 38" Circulation. 119: e602-e603. DOI: 10.1161/Circulationaha.108.844050  0.311
2008 Arnold SV, Morrow DA, Wang K, Lei Y, Mahoney EM, Scirica BM, Braunwald E, Cohen DJ. Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial. Circulation. Cardiovascular Quality and Outcomes. 1: 107-15. PMID 20031797 DOI: 10.1161/Circoutcomes.108.798009  0.345
2008 Scirica BM, Cannon CP, Sabatine MS, Jarolim P, Sloane S, Rifai N, Braunwald E, Morrow DA. Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death. Clinical Chemistry. 55: 265-73. PMID 19074516 DOI: 10.1373/Clinchem.2008.117192  0.368
2008 Cannon CP, Giugliano RP, Blazing MA, Harrington RA, Peterson JL, Sisk CM, Strony J, Musliner TA, McCabe CH, Veltri E, Braunwald E, Califf RM. Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes. American Heart Journal. 156: 826-32. PMID 19061694 DOI: 10.1016/J.Ahj.2008.07.023  0.349
2008 Wiviott SD, Braunwald E, Angiolillo DJ, Meisel S, Dalby AJ, Verheugt FW, Goodman SG, Corbalan R, Purdy DA, Murphy SA, McCabe CH, Antman EM. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38. Circulation. 118: 1626-36. PMID 18757948 DOI: 10.1161/Circulationaha.108.791061  0.347
2008 Brilakis ES, de Lemos JA, Cannon CP, Wiviott SD, Murphy SA, Morrow DA, Sabatine MS, Banerjee S, Blazing MA, Califf RM, Braunwald E. Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials). The American Journal of Cardiology. 102: 552-8. PMID 18721511 DOI: 10.1016/J.Amjcard.2008.04.024  0.415
2008 Murphy SA, Antman EM, Wiviott SD, Weerakkody G, Morocutti G, Huber K, Lopez-Sendon J, McCabe CH, Braunwald E. Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial. European Heart Journal. 29: 2473-9. PMID 18682445 DOI: 10.1093/Eurheartj/Ehn362  0.366
2008 Brockenbrough EC, Morrow AG, Talbert J, Braunwald E. PERCUTANEOUS PUNCTURE OF THE LEFT VENTRICLE. British Heart Journal. 23: 643-8. PMID 18610165 DOI: 10.1136/Hrt.23.6.643  0.356
2008 O'Donoghue M, Boden WE, Braunwald E, Cannon CP, Clayton TC, Winter RJd, Fox KAA, Lagerqvist B, McCullough PA, Murphy SA, Spacek R, Swahn E, Wallentin L, Windhausen F, Sabatine MS. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. Jama. 300: 71-80. PMID 18594042 DOI: 10.1001/Jama.300.1.71  0.322
2008 Antman EM, Wiviott SD, Murphy SA, Voitk J, Hasin Y, Widimsky P, Chandna H, Macias W, McCabe CH, Braunwald E. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis. Journal of the American College of Cardiology. 51: 2028-33. PMID 18498956 DOI: 10.1016/J.Jacc.2008.04.002  0.401
2008 Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. Clinical considerations with the use of antiplatelet therapy in patients undergoing percutaneous coronary intervention. Clinical Cardiology. 31: I28-35. PMID 18481820 DOI: 10.1002/Clc.20359  0.35
2008 Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. Investigating the mechanisms of hyporesponse to antiplatelet approaches. Clinical Cardiology. 31: I21-7. PMID 18481819 DOI: 10.1002/Clc.20360  0.351
2008 Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes. Clinical Cardiology. 31: I2-9. PMID 18481818 DOI: 10.1002/Clc.20362  0.367
2008 Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary intervention. Clinical Cardiology. 31: I17-20. PMID 18481817 DOI: 10.1002/Clc.20363  0.34
2008 Braunwald E. Biomarkers in heart failure. The New England Journal of Medicine. 358: 2148-2159. PMID 18480207 DOI: 10.1056/Nejmra0800239  0.354
2008 Wiviott SD, Braunwald E, Murphy SA, Antman EM. A perspective on the efficacy and safety of intensive antiplatelet therapy in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38. The American Journal of Cardiology. 101: 1367-70. PMID 18435974 DOI: 10.1016/J.Amjcard.2008.03.016  0.405
2008 Gibson CM, Pride YB, Buros JL, Kunadian V, Southard MC, Harrigan CJ, Ciaglo LN, Sabatine MS, Cannon CP, Braunwald E. Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy. The American Journal of Cardiology. 101: 1232-8. PMID 18435949 DOI: 10.1016/J.Amjcard.2007.12.023  0.399
2008 Wiviott SD, Braunwald E, McCabe CH, Horvath I, Keltai M, Herrman JP, Van de Werf F, Downey WE, Scirica BM, Murphy SA, Antman EM. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. Lancet (London, England). 371: 1353-63. PMID 18377975 DOI: 10.1016/S0140-6736(08)60422-5  0.353
2008 Mielniczuk LM, Pfeffer MA, Lewis EF, Blazing MA, Lemos JAd, Shui A, Mohanavelu S, Califf RM, Braunwald E. Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome. American Heart Journal. 155: 725-731. PMID 18371483 DOI: 10.1016/J.Ahj.2007.11.031  0.34
2008 Miller M, Cannon CP, Murphy SA, Qin J, Ray KK, Braunwald E. Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. Journal of the American College of Cardiology. 51: 724-30. PMID 18279736 DOI: 10.1016/J.Jacc.2007.10.038  0.362
2008 Iakoubova OA, Sabatine MS, Rowland CM, Tong CH, Catanese JJ, Ranade K, Simonsen KL, Kirchgessner TG, Cannon CP, Devlin JJ, Braunwald E. Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study. Journal of the American College of Cardiology. 51: 449-55. PMID 18222355 DOI: 10.1016/J.Jacc.2007.10.017  0.325
2008 Iakoubova OA, Tong CH, Rowland CM, Kirchgessner TG, Young BA, Arellano AR, Shiffman D, Sabatine MS, Campos H, Packard CJ, Pfeffer MA, White TJ, Braunwald E, Shepherd J, Devlin JJ, et al. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials. Journal of the American College of Cardiology. 51: 435-43. PMID 18222353 DOI: 10.1016/J.Jacc.2007.05.057  0.399
2008 Ahmed S, Cannon CP, Giugliano RP, Murphy SA, Morrow DA, Antman EM, Braunwald E, Gibson CM. The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes. International Journal of Cardiology. 131: 105-12. PMID 18187215 DOI: 10.1016/J.Ijcard.2007.09.006  0.319
2008 Sabatine MS, Ploughman L, Simonsen KL, Iakoubova OA, Kirchgessner TG, Ranade K, Tsuchihashi Z, Zerba KE, Long DU, Tong CH, Packard CJ, Pfeffer MA, Devlin JJ, Shepherd J, Campos H, ... ... Braunwald E, et al. Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 562-567. PMID 18174457 DOI: 10.1161/Atvbaha.107.156653  0.367
2008 Morrow DA, Wang Y, Croce K, Sakuma M, Sabatine MS, Gao H, Pradhan AD, Healy AM, Buros J, McCabe CH, Libby P, Cannon CP, Braunwald E, Simon DI. Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. American Heart Journal. 155: 49-55. PMID 18082488 DOI: 10.1016/J.Ahj.2007.08.018  0.411
2008 Olenchock BA, Wiviott SD, Murphy SA, Cannon CP, Rifai N, Braunwald E, Morrow DA. Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16 Journal of Thrombosis and Thrombolysis. 26: 79-84. PMID 17917707 DOI: 10.1007/S11239-007-0156-Z  0.355
2008 Ahmed A, Pitt B, Rahimtoola SH, Waagstein F, White M, Love TE, Braunwald E. Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial. International Journal of Cardiology. 123: 138-46. PMID 17382417 DOI: 10.1016/J.Ijcard.2006.12.001  0.316
2008 Braunwald E. Edmund H. Sonnenblick Journal of Clinical Investigation. 118: 390-390. DOI: 10.1172/Jci34710  0.357
2008 VALENCIASERRANO F, LAMAS G, MITCHELL G, FLAKER G, ROULEAU J, BRAUNWALD E, SOLOMON S, PFEFFER M. Pulse pressure and the risk of heart failure hospitalization after acute myocardial infarction: insights from the SAVE trial European Journal of Heart Failure Supplements. 7: 142-142. DOI: 10.1016/S1567-4215(08)60403-8  0.404
2007 Gibson CM, Murphy SA, Pride YB, Kirtane AJ, Aroesty JM, Stein EB, Ciaglo LN, Southard MC, Sabatine MS, Cannon CP, Braunwald E. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study. American Heart Journal. 155: 133-9. PMID 18082504 DOI: 10.1016/J.Ahj.2007.08.034  0.405
2007 Wiviott SD, Trenk D, Frelinger AL, O'Donoghue M, Neumann FJ, Michelson AD, Angiolillo DJ, Hod H, Montalescot G, Miller DL, Jakubowski JA, Cairns R, Murphy SA, McCabe CH, Antman EM, ... Braunwald E, et al. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial. Circulation. 116: 2923-32. PMID 18056526 DOI: 10.1161/Circulationaha.107.740324  0.352
2007 Pollack CV, Braunwald E. 2007 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice. Annals of Emergency Medicine. 51: 591-606. PMID 18037193 DOI: 10.1016/J.Annemergmed.2007.09.004  0.364
2007 de Lemos JA, Morrow DA, Blazing MA, Jarolim P, Wiviott SD, Sabatine MS, Califf RM, Braunwald E. Serial Measurement of Monocyte Chemoattractant Protein-1 After Acute Coronary Syndromes. Results From the A to Z Trial Journal of the American College of Cardiology. 50: 2117-2124. PMID 18036447 DOI: 10.1016/J.Jacc.2007.06.057  0.375
2007 Morrow DA, Antman EM, Murphy SA, Qin J, Ruda M, Guneri S, Jacob AJ, Budaj A, Braunwald E. Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial. American Heart Journal. 154: 1078-84, 1084.e1. PMID 18035078 DOI: 10.1016/J.Ahj.2007.07.027  0.403
2007 Solomon SD, Lin J, Solomon CG, Jablonski KA, Rice MM, Steffes M, Domanski M, Hsia J, Gersh BJ, Arnold JM, Rouleau J, Braunwald E, Pfeffer MA. Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. Circulation. 116: 2687-93. PMID 18025537 DOI: 10.1161/Circulationaha.107.723270  0.336
2007 Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM. Prasugrel versus clopidogrel in patients with acute coronary syndromes. The New England Journal of Medicine. 357: 2001-15. PMID 17982182 DOI: 10.1056/Nejmoa0706482  0.352
2007 Ruff CT, Wiviott SD, Morrow DA, Mohanavelu S, Murphy SA, Antman EM, Braunwald E. TIMI Risk Index and the Benefit of Enoxaparin in Patients with ST-Elevation Myocardial Infarction American Journal of Medicine. 120: 993-998. PMID 17976428 DOI: 10.1016/J.Amjmed.2007.08.020  0.431
2007 Murphy SA, Cannon CP, Wiviott SD, Lemos JAd, Blazing MA, McCabe CH, Califf RM, Braunwald E. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials). American Journal of Cardiology. 100: 1047-1051. PMID 17884359 DOI: 10.1016/J.Amjcard.2007.04.053  0.326
2007 Scirica BM, Morrow DA, Hod H, Murphy SA, Belardinelli L, Hedgepeth CM, Molhoek P, Verheugt FWA, Gersh BJ, McCabe CH, Braunwald E. Effect of Ranolazine, an Antianginal Agent With Novel Electrophysiological Properties, on the Incidence of Arrhythmias in Patients With Non–ST-Segment–Elevation Acute Coronary Syndrome Results From the Metabolic Efficiency With Ranolazine for Less Ischemia in Non–ST-Elevation Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) Randomized Controlled Trial Circulation. 116: 1647-1652. PMID 17804441 DOI: 10.1161/Circulationaha.107.724880  0.438
2007 Scirica BM, Morrow DA, Cannon CP, Lemos JAd, Murphy S, Sabatine MS, Wiviott SD, Rifai N, McCabe CH, Braunwald E. Clinical Application of C-Reactive Protein Across the Spectrum of Acute Coronary Syndromes Clinical Chemistry. 53: 1800-1807. PMID 17717132 DOI: 10.1373/Clinchem.2007.087957  0.377
2007 Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. Journal of the American College of Cardiology. 50: 205-14. PMID 17631211 DOI: 10.1016/J.Jacc.2007.03.038  0.315
2007 Scirica BM, Morrow DA, Sadowski Z, Ruda M, Nicolau JC, Giugliano RP, Wiviott SD, Sabatine MS, Shui A, Antman EM, Braunwald E. A strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study. European Heart Journal. 28: 2070-6. PMID 17600039 DOI: 10.1093/Eurheartj/Ehm210  0.373
2007 Murphy SA, Gibson CM, Morrow DA, Werf FVd, Menown IB, Goodman SG, Mahaffey KW, Cohen M, McCabe CH, Antman EM, Braunwald E. Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis. European Heart Journal. 28: 2077-2086. PMID 17600038 DOI: 10.1093/Eurheartj/Ehm224  0.384
2007 Giugliano RP, Wiviott SD, Stone PH, Simon DI, Schweiger MJ, Bouchard A, Leesar MA, Goulder MA, Deitcher SR, McCabe CH, Braunwald E. Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial. Journal of the American College of Cardiology. 49: 2398-407. PMID 17599602 DOI: 10.1016/J.Jacc.2007.02.065  0.353
2007 Braunwald E. Reducing myocardial injury by minimizing imbalance between oxygen supply and demand. Anesthesiology. 107: 161-3. PMID 17585228 DOI: 10.1097/01.Anes.0000268391.73266.5B  0.415
2007 Sabatine MS, Morrow DA, Dalby A, Pfisterer M, Duris T, Lopez-Sendon J, Murphy SA, Gao R, Antman EM, Braunwald E. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel. Journal of the American College of Cardiology. 49: 2256-63. PMID 17560290 DOI: 10.1016/J.Jacc.2007.01.092  0.375
2007 Fox KAA, Antman EM, Montalescot G, Agewall S, SomaRaju B, Verheugt FWA, Lopez-Sendon J, Hod H, Murphy SA, Braunwald E. The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial. Journal of the American College of Cardiology. 49: 2249-2255. PMID 17560289 DOI: 10.1016/J.Jacc.2006.12.049  0.343
2007 Gibson CM, Murphy SA, Montalescot G, Morrow DA, Ardissino D, Cohen M, Gulba DC, Kracoff OH, Lewis BS, Roguin N, Antman EM, Braunwald E. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial. Journal of the American College of Cardiology. 49: 2238-46. PMID 17560287 DOI: 10.1016/J.Jacc.2007.01.093  0.405
2007 Ray KK, Morrow DA, Sabatine MS, Shui A, Rifai N, Cannon CP, Braunwald E. Long-term prognostic value of neopterin: A novel marker of monocyte activation in patients with acute coronary syndrome Circulation. 115: 3071-3078. PMID 17548728 DOI: 10.1161/Circulationaha.106.666511  0.387
2007 Mega JL, Morrow DA, Östör E, Dorobantu M, Qin J, Antman EM, Braunwald E. Outcomes and optimal antithrombotic therapy in women undergoing fibrinolysis for ST-elevation myocardial infarction Circulation. 115: 2822-2828. PMID 17515461 DOI: 10.1161/Circulationaha.106.679548  0.333
2007 Morrow DA, Scirica BM, Karwatowska-Prokopczuk E, Murphy SA, Budaj A, Varshavsky S, Wolff AA, Skene A, McCabe CH, Braunwald E. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. Jama. 297: 1775-83. PMID 17456819 DOI: 10.1001/Jama.297.16.1775  0.382
2007 White HD, Braunwald E, Murphy SA, Jacob AJ, Gotcheva N, Polonetsky L, Antman EM. Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25. European Heart Journal. 28: 1066-71. PMID 17456482 DOI: 10.1093/Eurheartj/Ehm081  0.371
2007 Ray KK, Cannon CP, Morrow DA, Kirtane AJ, Buros J, Rifai N, McCabe CH, Gibson CM, Braunwald E. Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18. European Heart Journal. 28: 806-13. PMID 17403721 DOI: 10.1093/Eurheartj/Ehm010  0.314
2007 Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation. 115: 1528-36. PMID 17372173 DOI: 10.1161/Circulationaha.106.649939  0.417
2006 Scirica BM, Cannon CP, Cooper R, Aster RH, Brassard J, McCabe CH, Charlesworth A, Skene AM, Braunwald E. Drug-induced thrombocytopenia and thrombosis: Evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the orbofiban in patients with unstable coronary syndromes-(OPUS-TIMI 16) trial Journal of Thrombosis and Thrombolysis. 22: 95-102. PMID 17008974 DOI: 10.1007/S11239-006-8669-4  0.333
2006 Gibson CM, Kirtane AJ, Morrow DA, Palabrica TM, Murphy SA, Stone PH, Scirica BM, Jennings LK, Herrmann HC, Cohen DJ, McCabe CH, Braunwald E. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30). American Heart Journal. 152: 756-61. PMID 16996854 DOI: 10.1016/J.Ahj.2006.04.016  0.425
2006 Gibson CM, Kirtane AJ, Murphy SA, Rohrbeck S, Menon V, Lins J, Kazziha S, Rokos I, Shammas NW, Palabrica TM, Fish P, McCabe CH, Braunwald E. Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial. American Heart Journal. 152: 668-75. PMID 16996831 DOI: 10.1016/J.Ahj.2006.06.003  0.397
2006 Wiviott SD, Antman EM, Gibson CM, Montalescot G, Riesmeyer J, Weerakkody G, Winters KJ, Warmke JW, McCabe CH, Braunwald E. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38). American Heart Journal. 152: 627-35. PMID 16996826 DOI: 10.1016/J.Ahj.2006.04.012  0.38
2006 Ahmed S, Cannon CP, Murphy SA, Braunwald E. Acute coronary syndromes and diabetes: Is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial European Heart Journal. 27: 2323-2329. PMID 16954134 DOI: 10.1093/Eurheartj/Ehl220  0.364
2006 Morrow DA, Lemos JAd, Sabatine MS, Wiviott SD, Blazing MA, Shui A, Rifai N, Califf RM, Braunwald E. Clinical Relevance of C-Reactive Protein During Follow-Up of Patients With Acute Coronary Syndromes in the Aggrastat-to-Zocor Trial Circulation. 114: 281-288. PMID 16847150 DOI: 10.1161/Circulationaha.106.628909  0.341
2006 Scirica BM, Sabatine MS, Morrow DA, Gibson CM, Murphy SA, Wiviott SD, Giugliano RP, McCabe CH, Cannon CP, Braunwald E. The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study. Journal of the American College of Cardiology. 48: 37-42. PMID 16814646 DOI: 10.1016/J.Jacc.2006.02.052  0.366
2006 Solomon SD, Rice MM, A Jablonski K, Jose P, Domanski M, Sabatine M, Gersh BJ, Rouleau J, Pfeffer MA, Braunwald E. Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial. Circulation. 114: 26-31. PMID 16801465 DOI: 10.1161/Circulationaha.105.592733  0.319
2006 Mega JL, Morrow DA, Cannon CP, Murphy S, Cairns R, Ridker PM, Braunwald E. Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy Journal of Thrombosis and Thrombolysis. 22: 71-76. PMID 16786236 DOI: 10.1007/S11239-006-8081-0  0.306
2006 Ly HQ, Kirtane AJ, Murphy SA, Buros J, Cannon CP, Braunwald E, Gibson CM. Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials). The American Journal of Cardiology. 98: 1-5. PMID 16784909 DOI: 10.1016/J.Amjcard.2006.01.046  0.331
2006 Gibson CM, Morrow DA, Murphy SA, Palabrica TM, Jennings LK, Stone PH, Lui HH, Bulle T, Lakkis N, Kovach R, Cohen DJ, Fish P, McCabe CH, Braunwald E. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial. Journal of the American College of Cardiology. 47: 2364-73. PMID 16781360 DOI: 10.1016/J.Jacc.2005.12.077  0.367
2006 Roe MT, Peterson ED, Newby LK, Chen AY, Pollack CV, Brindis RG, Harrington RA, Christenson RH, Smith SC, Califf RM, Braunwald E, Gibler WB, Ohman EM. The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes. American Heart Journal. 151: 1205-13. PMID 16781220 DOI: 10.1016/J.Ahj.2005.08.006  0.353
2006 Morrow DA, Scirica BM, Karwatowska-Prokopczuk E, Skene A, McCabe CH, Braunwald E. Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial. American Heart Journal. 151: 1186.e1-9. PMID 16781216 DOI: 10.1016/J.Ahj.2006.01.004  0.385
2006 Scirica BM, Morrow DA, Cannon CP, Ray KK, Sabatine MS, Jarolim P, Shui A, McCabe CH, Braunwald E. Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study. Journal of the American College of Cardiology. 47: 2326-31. PMID 16750703 DOI: 10.1016/J.Jacc.2006.03.034  0.376
2006 Bhadriraju S, Ray KK, DeFranco AC, Barber K, Bhadriraju P, Murphy SA, Morrow DA, McCabe CH, Gibson CM, Cannon CP, Braunwald E. Association between blood glucose and long-term mortality in patients with acute coronary syndromes in the OPUS-TIMI 16 trial. The American Journal of Cardiology. 97: 1573-7. PMID 16728216 DOI: 10.1016/J.Amjcard.2005.12.046  0.304
2006 Domanski MJ, Jablonski KA, Rice MM, Fowler SE, Braunwald E. Obesity and cardiovascular events in patients with established coronary disease. European Heart Journal. 27: 1416-22. PMID 16707546 DOI: 10.1093/Eurheartj/Ehl022  0.32
2006 Mason DT, Braunwald E. STUDIES ON DIGITALIS. IX. EFFECTS OF OUABAIN ON THE NONFAILING HUMAN HEART. The Journal of Clinical Investigation. 42: 1105-11. PMID 16695907 DOI: 10.1097/00132586-196410000-00023  0.332
2006 Braunwald E, Bloodwell RD, Goldberg LI, Morrow AG. STUDIES ON DIGITALIS. IV. OBSERVATIONS IN MAN ON THE EFFECTS OF DIGITALIS PREPARATIONS ON THE CONTRACTILITY OF THE NON-FAILING HEART AND ON TOTAL VASCULAR RESISTANCE. The Journal of Clinical Investigation. 40: 52-9. PMID 16695846 DOI: 10.1172/Jci104236  0.318
2006 Dumaine R, Gibson CM, Murphy SA, Southard M, Ly HQ, McCabe CH, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Association of a history of systemic hypertension with mortality, thrombotic, and bleeding complications following non-ST-segment elevation acute coronary syndrome. Journal of Clinical Hypertension (Greenwich, Conn.). 8: 315-22. PMID 16687939 DOI: 10.1111/J.1524-6175.2006.05384.X  0.41
2006 Braunwald E. Epilogue: what do clinicians expect from imagers? Journal of the American College of Cardiology. 47: C101-3. PMID 16631504 DOI: 10.1016/J.Jacc.2005.10.072  0.34
2006 Jose P, Tomson C, Skali H, Rouleau J, Braunwald E, Arnold JM, Cuddy T, Sussex B, Bernstein V, Pfeffer M, Solomon S. Influence of proteinuria on cardiovascular risk and response to angiotensin-converting enzyme inhibition after myocardial infarction. Journal of the American College of Cardiology. 47: 1725-7. PMID 16631015 DOI: 10.1016/J.Jacc.2006.01.047  0.371
2006 Wiviott SD, Morrow DA, Frederick PD, Antman EM, Braunwald E. Application of the Thrombolysis In Myocardial Infarction Risk Index in Non-ST-Segment Elevation Myocardial Infarction. Evaluation of Patients in the National Registry of Myocardial Infarction Journal of the American College of Cardiology. 47: 1553-1558. PMID 16630990 DOI: 10.1016/J.Jacc.2005.11.075  0.403
2006 Ahmed S, Antman EM, Murphy SA, Giugliano RP, Cannon CP, White H, Morrow DA, Braunwald E. Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials). Journal of Thrombosis and Thrombolysis. 21: 119-29. PMID 16622607 DOI: 10.1007/S11239-006-5485-9  0.35
2006 Antman EM, Morrow DA, McCabe CH, Murphy SA, Ruda M, Sadowski Z, Budaj A, López-Sendón JL, Guneri S, Jiang F, White HD, Fox KA, Braunwald E. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. The New England Journal of Medicine. 354: 1477-88. PMID 16537665 DOI: 10.1056/Nejmoa060898  0.382
2006 O'Donoghue M, Morrow DA, Sabatine MS, Murphy SA, McCabe CH, Cannon CP, Braunwald E. Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin or atorVastatin evaluation and infection therapy-thrombolysis in myocardial infarction) trial Circulation. 113: 1745-1752. PMID 16537575 DOI: 10.1161/Circulationaha.105.612630  0.345
2006 Wiviott SD, Lemos JAd, Cannon CP, Blazing M, Murphy SA, McCabe CH, Califf R, Braunwald E. A Tale of Two Trials A Comparison of the Post–Acute Coronary Syndrome Lipid-Lowering Trials A to Z and PROVE IT–TIMI 22 Circulation. 113: 1406-1414. PMID 16534008 DOI: 10.1161/Circulationaha.105.586347  0.339
2006 Januzzi JL, Newby LK, Murphy SA, Pieper K, Antman EM, Morrow DA, Sabatine MS, Ohman EM, Cannon CP, Braunwald E. Predicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: Clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies American Heart Journal. 151: 360-366. PMID 16442899 DOI: 10.1016/J.Ahj.2005.04.021  0.368
2006 Maisel AS, Bhalla V, Braunwald E. Cardiac biomarkers: a contemporary status report. Nature Clinical Practice. Cardiovascular Medicine. 3: 24-34. PMID 16391615 DOI: 10.1038/Ncpcardio0405  0.346
2006 Ray KK, Cannon CP, Cairns R, Morrow DA, Rifai N, Kirtane AJ, McCabe CH, Skene AM, Gibson CM, Ridker PM, Braunwald E. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial. Journal of the American College of Cardiology. 46: 1417-24. PMID 16226164 DOI: 10.1016/J.Jacc.2005.08.024  0.318
2006 Ray KK, Cannon CP, McCabe CH, Cairns R, Tonkin AM, Sacks FM, Jackson G, Braunwald E. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. Journal of the American College of Cardiology. 46: 1405-10. PMID 16226162 DOI: 10.1016/J.Jacc.2005.03.077  0.355
2006 Maisel AS, Bhalla V, Braunwald E. Erratum: Cardiac biomarkers: a contemporary status report Nature Clinical Practice Cardiovascular Medicine. 3: 288-288. DOI: 10.1038/Ncpcardio0514  0.349
2005 Morrow DA, Lemos JAD, Blazing MA, Sabatine MS, Murphy SA, Jarolim P, White HD, Fox KAA, Califf RM, Braunwald E. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. Jama. 294: 2866-2871. PMID 16352794 DOI: 10.1001/Jama.294.22.2866  0.367
2005 Sabatine MS, Morrow DA, Montalescot G, Dellborg M, Leiva-Pons JL, Keltai M, Murphy SA, McCabe CH, Gibson CM, Cannon CP, Antman EM, Braunwald E. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial. Circulation. 112: 3846-54. PMID 16291601 DOI: 10.1161/Circulationaha.105.595397  0.396
2005 Wiviott SD, Cannon CP, Morrow DA, Ray KK, Pfeffer MA, Braunwald E. Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: A PROVE IT-TIMI 22 substudy Journal of the American College of Cardiology. 46: 1411-1416. PMID 16226163 DOI: 10.1016/J.Jacc.2005.04.064  0.313
2005 Skali H, Zornoff LA, Pfeffer MA, Arnold MO, Lamas GA, Moyé LA, Plappert T, Rouleau JL, Sussex BA, St John Sutton M, Braunwald E, Solomon SD. Prognostic use of echocardiography 1 year after a myocardial infarction. American Heart Journal. 150: 743-9. PMID 16209977 DOI: 10.1016/J.Ahj.2004.10.033  0.424
2005 Moghbeli N, Kirtane AJ, Ray KK, Murphy SA, Gibson CM, Braunwald E, Cannon CP. C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial). The American Journal of Cardiology. 96: 635-8. PMID 16125484 DOI: 10.1016/J.Amjcard.2005.04.033  0.343
2005 Ohman EM, Werf FVd, Antman EM, Califf RM, Lemos JAd, Gibson CM, Oliverio RL, Harrelson L, McCabe C, DiBattiste P, Braunwald E. Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: Results of a randomized trial American Heart Journal. 150: 79-88. PMID 16084152 DOI: 10.1016/J.Ahj.2005.01.007  0.353
2005 Pinto DS, Skolnick AH, Kirtane AJ, Murphy SA, Barron HV, Giugliano RP, Cannon CP, Braunwald E, Gibson CM. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. Journal of the American College of Cardiology. 46: 178-80. PMID 15992655 DOI: 10.1016/J.Jacc.2005.03.052  0.368
2005 Giugliano RP, Newby LK, Harrington RA, Gibson CM, Werf FVd, Armstrong P, Montalescot G, Gilbert J, Strony JT, Califf RM, Braunwald E. The Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non–ST-segment elevation acute coronary syndrome—Study design and rationale ☆ ☆☆ American Heart Journal. 149: 994-1002. PMID 15976780 DOI: 10.1016/J.Ahj.2005.03.029  0.386
2005 Wiviott SD, Antman EM, Winters KJ, Weerakkody G, Murphy SA, Behounek BD, Carney RJ, Lazzam C, McKay RG, McCabe CH, Braunwald E. Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial. Circulation. 111: 3366-73. PMID 15967851 DOI: 10.1161/Circulationaha.104.502815  0.345
2005 Mehta SR, Cannon CP, Fox KA, Wallentin L, Boden WE, Spacek R, Widimsky P, McCullough PA, Hunt D, Braunwald E, Yusuf S. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. Jama. 293: 2908-17. PMID 15956636 DOI: 10.1001/Jama.293.23.2908  0.387
2005 Kirtane AJ, Leder DM, Waikar SS, Chertow GM, Ray KK, Pinto DS, Karmpaliotis D, Burger AJ, Murphy SA, Cannon CP, Braunwald E, Gibson CM. Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates. Journal of the American College of Cardiology. 45: 1781-6. PMID 15936606 DOI: 10.1016/J.Jacc.2005.02.068  0.346
2005 Mega JL, Morrow DA, Sabatine MS, Zhao XQ, Snapinn SM, Dibattiste PM, Gibson CM, Antman EM, Braunwald E, Théroux P. Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: Observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial American Heart Journal. 149: 846-850. PMID 15894966 DOI: 10.1016/J.Ahj.2004.08.042  0.383
2005 Smith CS, Cannon CP, McCabe CH, Murphy SA, Bentley J, Braunwald E. Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial. American Heart Journal. 149: 444-50. PMID 15864232 DOI: 10.1016/J.Ahj.2004.06.033  0.368
2005 Antman EM, Morrow DA, McCabe CH, Jiang F, White HD, Fox KA, Sharma D, Chew P, Braunwald E. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25). American Heart Journal. 149: 217-26. PMID 15846258 DOI: 10.1016/J.Ahj.2004.08.038  0.393
2005 Cannon CP, Braunwald E, McCabe CH, Grayston JT, Muhlestein B, Giugliano RP, Cairns R, Skene AM. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. The New England Journal of Medicine. 352: 1646-54. PMID 15843667 DOI: 10.1056/Nejmoa043528  0.32
2005 Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH, Gibson CM, Braunwald E. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation. 111: 2042-9. PMID 15824203 DOI: 10.1161/01.Cir.0000162477.70955.5F  0.357
2005 Sabatine MS, Cannon CP, Gibson CM, López-Sendón JL, Montalescot G, Theroux P, Claeys MJ, Cools F, Hill KA, Skene AM, McCabe CH, Braunwald E. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. The New England Journal of Medicine. 352: 1179-89. PMID 15758000 DOI: 10.1056/Nejmoa050522  0.421
2005 Gibson CM, Kirtane AJ, Boundy K, Ly H, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients. Journal of the American College of Cardiology. 45: 357-62. PMID 15680712 DOI: 10.1016/J.Jacc.2004.10.047  0.388
2005 Ray KK, Morrow DA, Gibson CM, Murphy S, Antman EM, Braunwald E. Predictors of the rise in vWF after ST elevation myocardial infarction: Implications for treatment strategies and clinical outcome. An ENTIRE-TIMI 23 substudy European Heart Journal. 26: 440-446. PMID 15673542 DOI: 10.1093/Eurheartj/Ehi104  0.418
2005 Kirtane AJ, Kosmidou I, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Gibson CM. Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy. The American Journal of Cardiology. 95: 337-42. PMID 15670541 DOI: 10.1016/J.Amjcard.2004.09.030  0.437
2005 Kirtane AJ, Martinezclark P, Rahman AM, Ray KK, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Roe MT, Harrington RA, Ohman EM, Braunwald E, Gibson CM. Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction. Journal of the American College of Cardiology. 45: 321-3. PMID 15653037 DOI: 10.1016/J.Jacc.2004.10.018  0.376
2005 Kirtane AJ, Weisbord A, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Ohman EM, Roe MT, Braunwald E, Gibson CM. Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction. The American Journal of Cardiology. 95: 224-7. PMID 15642554 DOI: 10.1016/J.Amjcard.2004.09.007  0.418
2005 Giugliano RP, Braunwald E. Baseline troponin in acute coronary syndromes managed invasively. The American Journal of Medicine. 117: 963-5. PMID 15629738 DOI: 10.1016/J.Amjmed.2004.11.002  0.427
2005 Dokainish H, Pillai M, Murphy SA, DiBattiste PM, Schweiger MJ, Lotfi A, Morrow DA, Cannon CP, Braunwald E, Lakkis N. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy. Journal of the American College of Cardiology. 45: 19-24. PMID 15629367 DOI: 10.1016/J.Jacc.2004.09.056  0.37
2005 Turakhia MP, Murphy SA, Pinto TL, Antman EM, Giugliano RP, Cannon CP, Braunwald E, Gibson CM. Association of platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction. The American Journal of Cardiology. 94: 1406-10. PMID 15566912 DOI: 10.1016/J.Amjcard.2004.08.015  0.403
2005 Gibson CM, Dumaine RL, Gelfand EV, Murphy SA, Morrow DA, Wiviott SD, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials. European Heart Journal. 25: 1998-2005. PMID 15541835 DOI: 10.1016/J.Ehj.2004.08.016  0.362
2005 Karmpaliotis D, Turakhia MP, Kirtane AJ, Murphy SA, Kosmidou I, Morrow DA, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Gibson CM. Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction. The American Journal of Cardiology. 94: 1113-7. PMID 15518603 DOI: 10.1016/J.Amjcard.2004.07.075  0.397
2005 Kenchaiah S, Davis BR, Braunwald E, Rouleau JL, Dagenais GR, Sussex B, Steingart RM, Brown EJ, Lamas GA, Gordon D, Bernstein V, Pfeffer MA. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial. American Heart Journal. 148: 356-64. PMID 15309009 DOI: 10.1016/J.Ahj.2004.02.011  0.427
2005 Smith C, Cannon C, McCabe C, Murphy S, Bentley J, Braunwald E. Early Initiation of Lipid-lowering Therapy for Acute Coronary Syndromes Improves Compliance With Guideline Recommendations: Observations From the Orbofiban in Patients With Unstable Coronary Syndromes (OPUS–TIMI-16) Trial Acc Current Journal Review. 14: 1-2. DOI: 10.1016/J.Accreview.2005.08.002  0.351
2005 Lemos JAd, Blazing MA, Califf RM, Wiviott SD, Braunwald E. High-Dose Statins in Acute Coronary Syndromes—Reply Jama. 293: 36-39. DOI: 10.1001/Jama.293.1.38-B  0.329
2004 Tokmakova MP, Skali H, Kenchaiah S, Braunwald E, Rouleau JL, Packer M, Chertow GM, Moyé LA, Pfeffer MA, Solomon SD. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study. Circulation. 110: 3667-73. PMID 15569840 DOI: 10.1161/01.Cir.0000149806.01354.Bf  0.335
2004 Sabatine MS, Morrow DA, Lemos JAd, Omland T, Desai MY, Tanasijevic M, Hall C, McCabe CH, Braunwald E. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia Journal of the American College of Cardiology. 44: 1988-1995. PMID 15542281 DOI: 10.1016/J.Jacc.2004.07.057  0.357
2004 Murcia AM, Hennekens CH, Lamas GA, Jiménez-Navarro M, Rouleau JL, Flaker GC, Goldman S, Skali H, Braunwald E, Pfeffer MA. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. Archives of Internal Medicine. 164: 2273-9. PMID 15534166 DOI: 10.1001/Archinte.164.20.2273  0.394
2004 Braunwald E, Domanski MJ, Fowler SE, Geller NL, Gersh BJ, Hsia J, Pfeffer MA, Rice MM, Rosenberg YD, Rouleau JL. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. The New England Journal of Medicine. 351: 2058-68. PMID 15531767 DOI: 10.1056/Nejmoa042739  0.468
2004 Kashani A, Giugliano RP, Antman EM, Morrow DA, Gibson CM, Murphy SA, Braunwald E. Severity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarction European Heart Journal. 25: 1702-1710. PMID 15451148 DOI: 10.1016/J.Ehj.2004.05.009  0.399
2004 Lemos JAd, Blazing MA, Wiviott SD, Brady WE, White HD, Fox KAA, Palmisano J, Ramsey KE, Bilheimer DW, Lewis EF, Pfeffer M, Califf RM, Braunwald E. Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial European Heart Journal. 25: 1688-1694. PMID 15451146 DOI: 10.1016/J.Ehj.2004.06.028  0.357
2004 Morrow DA, Sabatine MS, Antman EM, Cannon CP, Braunwald E, Theroux P. Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS) American Journal of Cardiology. 94: 774-776. PMID 15374786 DOI: 10.1016/J.Amjcard.2004.05.065  0.378
2004 Sadanandan S, Cannon CP, Chekuri K, Murphy SA, DiBattiste PM, Morrow DA, Lemos JAd, Braunwald E, Gibson CM. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. Journal of the American College of Cardiology. 44: 564-568. PMID 15358021 DOI: 10.1016/J.Jacc.2004.03.072  0.409
2004 de Lemos JA, Blazing MA, Wiviott SD, Lewis EF, Fox KA, White HD, Rouleau JL, Pedersen TR, Gardner LH, Mukherjee R, Ramsey KE, Palmisano J, Bilheimer DW, Pfeffer MA, Califf RM, ... Braunwald E, et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. Jama. 292: 1307-16. PMID 15337732 DOI: 10.1001/Jama.292.11.1307  0.322
2004 Gibson CM, Murphy SA, Kirtane AJ, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction Journal of the American College of Cardiology. 44: 980-987. PMID 15337207 DOI: 10.1016/J.Jacc.2004.05.059  0.39
2004 Gibson CM, Singh KP, Murphy SA, DiBattiste PM, Demopoulos LA, Cannon CP, Braunwald E. Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy) American Journal of Cardiology. 94: 492-494. PMID 15325937 DOI: 10.1016/J.Amjcard.2004.04.066  0.391
2004 Sadanandan S, Cannon CP, Gibson CM, Murphy SA, Dibattiste PM, Braunwald E. A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non-ST-segment elevation myocardial infarction Journal of the American College of Cardiology. 44: 799-803. PMID 15312862 DOI: 10.1016/J.Jacc.2004.03.081  0.38
2004 Wiviott SD, Morrow DA, Frederick PD, Giugliano RP, Gibson CM, McCabe CH, Cannon CP, Antman EM, Braunwald E. Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction. Journal of the American College of Cardiology. 44: 783-9. PMID 15312859 DOI: 10.1016/J.Jacc.2004.05.045  0.388
2004 Gibson CM, Murphy SA, Morrow DA, Aroesty JM, Gibbons RJ, Gourlay SG, Barron HV, Giugliano RP, Antman EM, Braunwald E. Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction. American Heart Journal. 148: 336-40. PMID 15309006 DOI: 10.1016/J.Ahj.2003.12.044  0.395
2004 Van Der Harst P, Voors AA, Van Veldhuisen DJ, Miller M, Gotto AM, Paradis JM, LeLorier J, Auer J, Weber T, Eber B, Cannon CP, Braunwald E. Intensive versus moderate lipid lowering with statins after acute coronary syndromes [2] (multiple letters) New England Journal of Medicine. 351: 714-717. PMID 15306676 DOI: 10.1056/Nejm200408123510719  0.319
2004 Bach RG, Cannon CP, Weintraub WS, DiBattiste PM, Demopoulos LA, Anderson HV, DeLucca PT, Mahoney EM, Murphy SA, Braunwald E. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Annals of Internal Medicine. 141: 186-95. PMID 15289215 DOI: 10.7326/0003-4819-141-3-200408030-00007  0.348
2004 Gibson CM, Jennings LK, Murphy SA, Lorenz DP, Giugliano RP, Harrington RA, Cholera S, Krishnan R, Califf RM, Braunwald E. Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: an INTEGRITI (Integrilin and Tenecteplase in Acute Myocardial Infarction) substudy. Circulation. 110: 679-84. PMID 15262838 DOI: 10.1161/01.Cir.0000137912.11655.F6  0.362
2004 Mega JL, Morrow DA, Lemos JAd, Sabatine MS, Murphy SA, Rifai N, Gibson CM, Antman EM, Braunwald E. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. Journal of the American College of Cardiology. 44: 335-339. PMID 15261928 DOI: 10.1016/J.Jacc.2004.04.033  0.405
2004 Gardner GS, Frisch DR, Murphy SA, Kirtane AJ, Giugliano RP, Antman EM, Braunwald E, Gibson CM. Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries. The American Journal of Cardiology. 94: 178-81. PMID 15246895 DOI: 10.1016/J.Amjcard.2004.03.057  0.367
2004 Petersen JL, Mahaffey KW, Hasselblad V, Antman EM, Cohen M, Goodman SG, Langer A, Blazing MA, Le-Moigne-Amrani A, Lemos JAd, Nessel CC, Harrington RA, Ferguson JJ, Braunwald E, Califf RM. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview. Jama. 292: 89-96. PMID 15238596 DOI: 10.1001/Jama.292.1.89  0.345
2004 Blazing MA, De Lemos JA, White HD, Fox KAA, Verheugt FWA, Ardissino D, DiBattiste PM, Palmisano J, Bilheimer DW, Snapinn SM, Ramsey KE, Gardner LH, Hasselblad V, Pfeffer MA, Lewis EF, ... Braunwald E, et al. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: A randomized controlled trial Journal of the American Medical Association. 292: 55-64. PMID 15238591 DOI: 10.1001/Jama.292.1.55  0.391
2004 Giugliano RP, Sabatine MS, Gibson CM, Roe MT, Harrington RA, Murphy SA, Morrow DA, Antman EM, Braunwald E. Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion. The American Journal of Cardiology. 93: 1362-7, A5-6. PMID 15165915 DOI: 10.1016/J.Amjcard.2004.02.031  0.439
2004 Gibson CM, Karha J, Giugliano RP, Roe MT, Murphy SA, Harrington RA, Green CL, Schweiger MJ, Miklin JS, Baran KW, Palmeri S, Braunwald E, Krucoff MW. Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction. American Heart Journal. 147: 847-52. PMID 15131541 DOI: 10.1016/J.Ahj.2003.11.015  0.398
2004 Gibson CM, Karha J, Murphy SA, Lemos JAd, Morrow DA, Giugliano RP, Roe MT, Harrington RA, Cannon CP, Antman EM, Califf RM, Braunwald E. Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction. Journal of the American College of Cardiology. 43: 1170-1176. PMID 15063425 DOI: 10.1016/J.Jacc.2003.11.035  0.377
2004 Givertz MM, Braunwald E. Neurohormones in heart failure: predicting outcomes, optimizing care. European Heart Journal. 25: 281-2. PMID 14984914 DOI: 10.1016/J.Ehj.2003.12.013  0.353
2004 Wiviott SD, Cannon CP, Morrow DA, Murphy SA, Gibson CM, McCabe CH, Sabatine MS, Rifai N, Giugliano RP, DiBattiste PM, Demopoulos LA, Antman EM, Braunwald E. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy. Circulation. 109: 580-6. PMID 14769678 DOI: 10.1161/01.Cir.0000109491.66226.26  0.427
2004 Sabatine MS, Morrow DA, Giugliano RP, Murphy SA, Demopoulos LA, DiBattiste PM, Weintraub WS, McCabe CH, Antman EM, Cannon CP, Braunwald E. Implications of Upstream Glycoprotein IIb/IIIa Inhibition and Coronary Artery Stenting in the Invasive Management of Unstable Angina/Non–ST-Elevation Myocardial Infarction A Comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB Trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 Trial Circulation. 109: 874-880. PMID 14757697 DOI: 10.1161/01.Cir.0000112604.74713.35  0.409
2004 Braunwald E. The Simon Dack lecture. Cardiology: the past, the present, and the future. Journal of the American College of Cardiology. 42: 2031-41. PMID 14680723 DOI: 10.1016/J.Jacc.2003.08.025  0.315
2004 Giugliano RP, Braunwald E. Selecting the best reperfusion strategy in ST-elevation myocardial infarction: it's all a matter of time. Circulation. 108: 2828-30. PMID 14662688 DOI: 10.1161/01.Cir.0000106684.71725.98  0.405
2004 Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM. Comparison of Intensive and Moderate Lipid Lowering With Statins After Acute Coronary Symptoms Obstetrical & Gynecological Survey. 59: 522-524. DOI: 10.1097/00006254-200407000-00019  0.353
2004 Kenchaiah S, Pfeffer MA, St. John Sutton M, Plappert T, Rouleau J, Lamas GA, Sasson Z, Parker JO, Geltman EM, Braunwald E, Solomon SD. 1142-177 Antecedent hypertension and the risk of subsequent left ventricular remodelling after acute myocardial infarction: Insights from the survival and ventricular enlargement trial Journal of the American College of Cardiology. 43: A511. DOI: 10.1016/S0735-1097(04)92166-3  0.433
2004 Mega JL, Sabatine MS, Morrow DA, de Lemos JA, Murphy SA, McCabe CH, Cannon CP, Braunwald E. 884-4 Higher levels of thrombus precursor protein are associated with increased death and ischemic complications in patients with acute coronary syndromes Journal of the American College of Cardiology. 43: A306-A307. DOI: 10.1016/S0735-1097(04)91296-X  0.352
2004 Sabatine MS, Morrow DA, Giugliano RP, Murphy SA, McCabe CH, Gibson C, Cannon CP, Antman EM, Braunwald E. 1098-78 Low hemoglobin predicts worse clinical outcomes in acute coronary syndromes Journal of the American College of Cardiology. 43: A278. DOI: 10.1016/S0735-1097(04)91180-1  0.322
2004 Karha J, Cannon CP, Murphy SA, DiBattiste PM, Gibson C, Braunwald E. 1097-97 Safety of stress testing following an acute coronary syndrome Journal of the American College of Cardiology. 43: A277. DOI: 10.1016/S0735-1097(04)91176-X  0.3
2004 Kirtane AJ, Karmpaliotis D, Weisbord A, Bui A, Murphy SA, Budiu D, Kosmidou I, Aroesty JM, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Gibson C. 1060-101 Angiographically apparent thrombus after fibrinolytic administration is associated with impaired epicardial flow and myocardial perfusion in ST elevation myocardial infarction patients with open arteries Journal of the American College of Cardiology. 43: A262. DOI: 10.1016/S0735-1097(04)91114-X  0.417
2004 Karmpaliotis D, Kirtane AJ, Murphy SA, Kosmidou I, Budiu D, Guerra D, Giugliano R, Cannon CP, Antman EM, Braunwald E, Gibson C. 1060-83 Calcification of the culprit lesion is associated with adverse clinical outcomes in ST elevation myocardial infarction patients treated with fibrinolytic therapy Journal of the American College of Cardiology. 43: A261-A262. DOI: 10.1016/S0735-1097(04)91112-6  0.356
2004 Dumaine R, Gibson C, Pinto DS, Murphy SA, Morrow DA, Hobbach H, Wiviott SD, Cannon CP, Antman EM, Braunwald E. 1021-101 Association of glomerular filtration rate on presentation with subsequent mortality in non-ST elevation acute coronary syndromes Journal of the American College of Cardiology. 43: A250. DOI: 10.1016/S0735-1097(04)91062-5  0.331
2003 Gibson CM, Pinto DS, Murphy SA, Morrow DA, Hobbach HP, Wiviott SD, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. Journal of the American College of Cardiology. 42: 1535-43. PMID 14607434 DOI: 10.1016/J.Jacc.2003.06.001  0.383
2003 Braunwald E. Application of current guidelines to the management of unstable angina and non-ST-elevation myocardial infarction. Circulation. 108: III28-37. PMID 14605017 DOI: 10.1161/01.Cir.0000086952.14979.32  0.382
2003 Lewis EF, Moye LA, Rouleau JL, Sacks FM, Arnold JM, Warnica JW, Flaker GC, Braunwald E, Pfeffer MA. Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study. Journal of the American College of Cardiology. 42: 1446-53. PMID 14563590 DOI: 10.1016/S0735-1097(03)01057-X  0.413
2003 Karha J, Murphy SA, Kirtane AJ, Lemos JAd, Aroesty JM, Cannon CP, Antman EM, Braunwald E, Gibson CM. Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction American Journal of Cardiology. 92: 913-918. PMID 14556865 DOI: 10.1016/S0002-9149(03)00969-X  0.342
2003 MOSCOVITZ HL, GORDON AJ, BRAUNWALD E, AMRAM SS, SAPIN SO, LASSER RP, HIMMELSTEIN A, RAVITCH MM. The use of simultaneous left heart pressure pulse measurements in evaluating the effects of mitral valve surgery. The American Journal of Medicine. 18: 406-14. PMID 14349965 DOI: 10.1016/0002-9343(55)90220-5  0.336
2003 Giugliano RP, Braunwald E. Improving antithrombotic treatment in patients after myocardial infarction. Lancet (London, England). 362: 757. PMID 13678866 DOI: 10.1016/S0140-6736(03)14296-1  0.388
2003 GORDON AJ, KUHN L, AMRAM SS, DONOSO E, BRAUNWALD E. Left atrial pulmonary capillary, and oesophageal balloon pressure tracings in mitral valve disease. British Heart Journal. 18: 327-40. PMID 13342297 DOI: 10.1136/Hrt.18.3.327  0.303
2003 DONOSO E, BRAUNWALD E, JICK S, GRISHMAN A. Congenital heart block. The American Journal of Medicine. 20: 869-78. PMID 13326901 DOI: 10.1016/0002-9343(56)90207-8  0.395
2003 ELSTER SK, BRAUNWALD E, WOOD HF. A study of C-reactive protein in the serum of patients with congestive heart failure. American Heart Journal. 51: 533-41. PMID 13302128 DOI: 10.1016/0002-8703(56)90099-0  0.334
2003 GORDON AJ, BRAUNWALD E, MOSCOVITZ HL, AMRAM SS. Delay in transmission of a pressure impulse through a cardiac catheter and vinyl plastic tubing. Journal of Applied Physiology. 8: 573-4. PMID 13295180 DOI: 10.1152/Jappl.1956.8.5.573  0.301
Show low-probability matches.